<?xml version='1.0' encoding='UTF-8'?>
<DOCUMENTS>
<DOCUMENT>
  <ADMISSION>
    <HADM_ID>40</HADM_ID>
    <PATIENT>
      <SUBJECT_ID>186981</SUBJECT_ID>
      <SEX>F</SEX>
      <AGE_AT_ADMISSION>63</AGE_AT_ADMISSION>
      <AGE_AT_ADMISSION_GRP>35-64</AGE_AT_ADMISSION_GRP>
      <ADMISSION_DATE>2012-12-06 19:35:42</ADMISSION_DATE>
      <ADMISSION_DATE_YRMON>2012_12</ADMISSION_DATE_YRMON>
      <ADMISSION_DATE_MON_GRP>12</ADMISSION_DATE_MON_GRP>
      <ADMISSION_DATE_DAYMON_GRP>06</ADMISSION_DATE_DAYMON_GRP>
      <ADMISSION_DATE_DAYWEEK_GRP>4-Thu</ADMISSION_DATE_DAYWEEK_GRP>
      <ADMISSION_DATE_WEEK_GRP>49</ADMISSION_DATE_WEEK_GRP>
      <DISCHARGE_DATE>2012-12-06 16:35:42</DISCHARGE_DATE>
      <DOB>1949-08-26</DOB>
      <HOSPITAL_EXPIRE>N</HOSPITAL_EXPIRE>
      <ETHNICITY>WHITE</ETHNICITY>
      <ADMISSION_TYPE>EMERGENCY</ADMISSION_TYPE>
      <RELIGION>CATHOLIC</RELIGION>
      <ADMISSION_SOURCE>CLINIC REFERRAL/PREMATURE</ADMISSION_SOURCE>
      <OVERALL_PAYOR_GROUP>OTHER</OVERALL_PAYOR_GROUP>
      <MARITAL_STATUS>MARRIED</MARITAL_STATUS>
      <DOD>None</DOD>
      <AGE_AT_DEATH>(N/A)</AGE_AT_DEATH>
      <AGE_AT_DEATH_GRP>(N/A)</AGE_AT_DEATH_GRP>
    </PATIENT>
    <DRG>
      <CODE>541</CODE>
      <ITEMID>60775</ITEMID>
      <DESC>ECMO OR TRACH W MV 96+HRS OR PDX EXC FAC</DESC>
      <COST_WEIGHT>19.25</COST_WEIGHT>
      <COST_WEIGHT_GRP>5.0+</COST_WEIGHT_GRP>
      <DISPLAY>(541)ECMO OR TRACH W MV 96+HRS OR PDX EXC FAC</DISPLAY>
    </DRG>
    <ICD9>(427.5)CARDIAC ARREST</ICD9>
    <ICD9>(493.20)CHRONIC OBSTRUCTIVE ASTHMA, UNSPECIFIED</ICD9>
    <ICD9>(272.4)OTHER AND UNSPECIFIED HYPERLIPIDEMIA</ICD9>
    <ICD9>(512.8)OTHER SPONTANEOUS PNEUMOTHORAX</ICD9>
    <ICD9>(038.11)STAPHYLOCOCCUS AUREUS SEPTICEMIA</ICD9>
    <ICD9>(530.10)ESOPHAGITIS, UNSPECIFIED</ICD9>
    <ICD9>(346.90)MIGRAINE, UNSP W/O INTRA</ICD9>
    <ICD9>(E917.4)STATNRY OBJECT W/O FALL</ICD9>
    <ICU>
      <COUNT>1</COUNT>
      <ICU>
        <ICUSTAY_ID>177878</ICUSTAY_ID>
        <FIRST_CAREUNIT>MICU</FIRST_CAREUNIT>
        <LAST_CAREUNIT>MICU</LAST_CAREUNIT>
        <INTIME>2012-12-06 19:35:42</INTIME>
        <OUTTIME>2012-12-06 16:35:42</OUTTIME>
        <LOS>-1440</LOS>
        <LOS_GRP> &lt;00100</LOS_GRP>
        <MEDEVENTS>
          <EVENT>
            <NAME>Insulin</NAME>
            <OCCURRENCES>-1</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Propofol</NAME>
            <OCCURRENCES>-16</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Propofol</NAME>
            <OCCURRENCES>-1</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Nicardipine</NAME>
            <OCCURRENCES>-6</OCCURRENCES>
          </EVENT>
        </MEDEVENTS>
      </ICU>
    </ICU>
    <POEEVENTS>
      <EVENT>
        <NAME>Propofol</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Insulin</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ursodiol</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Metoprolol</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Dolasetron Mesylate</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hydrocortisone Na Succ.</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Vial</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Heparin Flush PICC 100 units per ml</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Cosyntropin</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>HYDROmorphone Dilaudid</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Oxycodone-Acetaminophen Elixir</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>D5W</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Levothyroxine Sodium</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Heparin</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Albumin 5 percent 25 g</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sertraline</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Aspirin</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Heparin Sodium</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
    </POEEVENTS>
    <LABEVENTS>
      <EVENT>
        <NAME>Glomerular filtration rate per 1.73 sq M.predicted by Creatinine-based formula MDRD</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular volume Entitic volume</NAME>
        <OCCURRENCES>-1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Thyroxine Mass per volume in Blood</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Barbiturates Presence in Serum Plasma or Blood</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatinine Mass per volume in Urine</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatine kinase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Chloride Moles per volume in Blood</NAME>
        <OCCURRENCES>-1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glomerular filtration rate per 1.73 sq M.predicted by Creatinine-based formula MDRD</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>TBX5 gene mutations found Identifier in Blood or Tissue by Molecular genetics method Nominal</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatinine Mass per volume in Urine</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Calcium Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Macrocytes Presence in Blood</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Activated partial thrombplastin time aPTT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bilirubin Mass per volume in Peritoneal fluid</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Thyrotropin Units per volume in Blood</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sodium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>-1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bilirubin Presence in Urine</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Neutrophils.band form per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Calcium Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Base excess in Blood</NAME>
        <OCCURRENCES>-2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hematocrit Volume Fraction of Blood</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Vancomycin Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Specific gravity of Urine by Test strip</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Prothrombin time PT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Phosphate Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes  per volume in Blood</NAME>
        <OCCURRENCES>-1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lactate dehydrogenase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hematocrit Volume Fraction of Blood</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>pH of Blood</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatine kinase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Alkaline phosphatase Enzymatic activity per volume in Blood</NAME>
        <OCCURRENCES>-1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Triglyceride Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anion gap in Blood</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular volume Entitic volume</NAME>
        <OCCURRENCES>-1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Chloride Moles per volume in Blood</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bilirubin Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Magnesium Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>-1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anion gap in Blood</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatine kinase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Microcytes Presence in Blood</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Prothrombin time PT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Mucus Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hemoglobin Mass per volume in Blood</NAME>
        <OCCURRENCES>-1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocytes  per area in Urine sediment by Microscopy high power field</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Serum</NAME>
        <OCCURRENCES>-1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lactate dehydrogenase Enzymatic activity per volume in Peritoneal fluid</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Amylase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Collection duration of Urine</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>FibrinplusFibrinogen fragments Mass per volume in Platelet poor plasma</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ketones Mass per volume in Urine</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular hemoglobin Entitic mass</NAME>
        <OCCURRENCES>-1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Oxygen Partial pressure in Blood</NAME>
        <OCCURRENCES>0</OCCURRENCES>
      </EVENT>
    </LABEVENTS>
  </ADMISSION>
</DOCUMENT>
<DOCUMENT>
  <ADMISSION>
    <HADM_ID>41</HADM_ID>
    <PATIENT>
      <SUBJECT_ID>963857</SUBJECT_ID>
      <SEX>M</SEX>
      <AGE_AT_ADMISSION>0</AGE_AT_ADMISSION>
      <AGE_AT_ADMISSION_GRP> &lt;01</AGE_AT_ADMISSION_GRP>
      <ADMISSION_DATE>2012-05-23 00:54:56</ADMISSION_DATE>
      <ADMISSION_DATE_YRMON>2012_05</ADMISSION_DATE_YRMON>
      <ADMISSION_DATE_MON_GRP>05</ADMISSION_DATE_MON_GRP>
      <ADMISSION_DATE_DAYMON_GRP>23</ADMISSION_DATE_DAYMON_GRP>
      <ADMISSION_DATE_DAYWEEK_GRP>3-Wed</ADMISSION_DATE_DAYWEEK_GRP>
      <ADMISSION_DATE_WEEK_GRP>21</ADMISSION_DATE_WEEK_GRP>
      <DISCHARGE_DATE>2012-05-24 14:54:56</DISCHARGE_DATE>
      <DOB>2012-05-23</DOB>
      <HOSPITAL_EXPIRE>N</HOSPITAL_EXPIRE>
      <ETHNICITY>WHITE</ETHNICITY>
      <ADMISSION_TYPE>NEWBORN</ADMISSION_TYPE>
      <RELIGION>CATHOLIC</RELIGION>
      <ADMISSION_SOURCE>PHYS REFERRAL/NORMAL DELI</ADMISSION_SOURCE>
      <OVERALL_PAYOR_GROUP>PRIVATE</OVERALL_PAYOR_GROUP>
      <MARITAL_STATUS>NONE</MARITAL_STATUS>
      <DOD>None</DOD>
      <AGE_AT_DEATH>(N/A)</AGE_AT_DEATH>
      <AGE_AT_DEATH_GRP>(N/A)</AGE_AT_DEATH_GRP>
    </PATIENT>
    <DRG>
      <CODE>385</CODE>
      <ITEMID>60572</ITEMID>
      <DESC>NEONATES, DIED OR TRANSFERRED TO ANOTHER</DESC>
      <COST_WEIGHT>1.38</COST_WEIGHT>
      <COST_WEIGHT_GRP>1.3-&lt;1.5</COST_WEIGHT_GRP>
      <DISPLAY>(385)NEONATES, DIED OR TRANSFERRED TO ANOTHER</DISPLAY>
    </DRG>
    <ICD9>(V05.3)NEED FOR PROPHYLACTIC VACCINATION AND INOCULATION</ICD9>
    <ICD9>(752.51)UNDESCENDED TESTIS</ICD9>
    <ICD9>(770.89)OTHER RESPIRATORY PROBLEMS AFTER BIRTH</ICD9>
    <ICU>
      <COUNT>1</COUNT>
      <ICU>
        <ICUSTAY_ID>500759</ICUSTAY_ID>
        <FIRST_CAREUNIT>NICU</FIRST_CAREUNIT>
        <LAST_CAREUNIT>NICU</LAST_CAREUNIT>
        <INTIME>2012-05-23 00:54:56</INTIME>
        <OUTTIME>2012-05-24 14:54:56</OUTTIME>
        <LOS>2880</LOS>
        <LOS_GRP>02000-&lt;03000</LOS_GRP>
        <MEDEVENTS/>
      </ICU>
    </ICU>
    <POEEVENTS>
      <EVENT>
        <NAME>Syringe Neonatal -D5W-</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>NEO-IV-Oxacillin</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>NEO-IV-Gentamicin</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sodium Acetate</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Syringe Neonatal -D5W-</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>NEO-PO-Ferrous Sulfate Elixir</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Send 500mg Vial</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>NEO-IV-Parenteral Nutrition</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>NEO-IV-Gentamicin</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sodium Chloride</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>NEO-PO-Ferrous Sulfate Elixir</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
    </POEEVENTS>
    <LABEVENTS>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Serum</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Myelocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Carbon dioxide Partial pressure in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
    </LABEVENTS>
    <NOTEEVENT>
      <CAREUNIT>NICU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>Respiratory Care Note</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT></TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>NICU</CAREUNIT>
      <CAREGIVER>RRT2</CAREGIVER>
      <TITLE>Neonatology Attending Note</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Inconsistently follows commands. No c/o CP. CT OF THE ABDOMEN WITH CONTRAST: Multiple sub-cm low attenuation lesions are scattered throughout the liver suggestive of simple cysts or hemangiomas. Monitor U/O. Chest examination showed poor air movement bilaterally, but equal. no insulin required at present. Major Surgical or Invasive Procedure: MRI/MRA repeat MRI/MRA Femoral line. No pathologically enlarged mediastinal or hilar lymph nodes are seen. Plan: Monitor hemodynamics, resp status &amp; labs; pulm toilet; inc activity as tol;wound care; nutrition support  Work-up also included a CT of the head which revealed a hyperintense area in the left temporal lobe. Atenolol 50 mg Tablet Sig: One (1) Tablet PO twice a day. Placed on nonrebreather during episodes of unresolved decreased O2 sats. HYDRALAZINE 10MG IV GIVEN AND TOLERATED WITH DECREASE IN SBP. </TEXT>
    </NOTEEVENT>
  </ADMISSION>
</DOCUMENT>
<DOCUMENT>
  <ADMISSION>
    <HADM_ID>42</HADM_ID>
    <PATIENT>
      <SUBJECT_ID>52244</SUBJECT_ID>
      <SEX>F</SEX>
      <AGE_AT_ADMISSION>0</AGE_AT_ADMISSION>
      <AGE_AT_ADMISSION_GRP> &lt;01</AGE_AT_ADMISSION_GRP>
      <ADMISSION_DATE>2012-02-12 07:38:31</ADMISSION_DATE>
      <ADMISSION_DATE_YRMON>2012_02</ADMISSION_DATE_YRMON>
      <ADMISSION_DATE_MON_GRP>02</ADMISSION_DATE_MON_GRP>
      <ADMISSION_DATE_DAYMON_GRP>12</ADMISSION_DATE_DAYMON_GRP>
      <ADMISSION_DATE_DAYWEEK_GRP>0-Sun</ADMISSION_DATE_DAYWEEK_GRP>
      <ADMISSION_DATE_WEEK_GRP>07</ADMISSION_DATE_WEEK_GRP>
      <DISCHARGE_DATE>2012-02-22 21:38:31</DISCHARGE_DATE>
      <DOB>2012-02-12</DOB>
      <HOSPITAL_EXPIRE>N</HOSPITAL_EXPIRE>
      <ETHNICITY>BLACK/AFRICAN AMERICAN</ETHNICITY>
      <ADMISSION_TYPE>NEWBORN</ADMISSION_TYPE>
      <RELIGION>NOT SPECIFIED</RELIGION>
      <ADMISSION_SOURCE>PHYS REFERRAL/NORMAL DELI</ADMISSION_SOURCE>
      <OVERALL_PAYOR_GROUP>PRIVATE</OVERALL_PAYOR_GROUP>
      <MARITAL_STATUS>NONE</MARITAL_STATUS>
      <DOD>None</DOD>
      <AGE_AT_DEATH>(N/A)</AGE_AT_DEATH>
      <AGE_AT_DEATH_GRP>(N/A)</AGE_AT_DEATH_GRP>
    </PATIENT>
    <DRG>
      <CODE>388</CODE>
      <ITEMID>60577</ITEMID>
      <DESC>PREMATURITY W/O MAJOR PROBLEMS</DESC>
      <COST_WEIGHT>1.88</COST_WEIGHT>
      <COST_WEIGHT_GRP>1.5-&lt;2.0</COST_WEIGHT_GRP>
      <DISPLAY>(388)PREMATURITY W/O MAJOR PROBLEMS</DISPLAY>
    </DRG>
    <ICD9>(V05.3)NEED FOR PROPHYLACTIC VACCINATION AND INOCULATION</ICD9>
    <ICD9>(779.3)FEEDING PROBLEMS IN NEWBORN</ICD9>
    <ICU>
      <COUNT>1</COUNT>
      <ICU>
        <ICUSTAY_ID>671643</ICUSTAY_ID>
        <FIRST_CAREUNIT>NICU</FIRST_CAREUNIT>
        <LAST_CAREUNIT>NICU</LAST_CAREUNIT>
        <INTIME>2012-02-12 07:38:31</INTIME>
        <OUTTIME>2012-02-22 21:38:31</OUTTIME>
        <LOS>15840</LOS>
        <LOS_GRP></LOS_GRP>
        <MEDEVENTS/>
      </ICU>
    </ICU>
    <POEEVENTS>
      <EVENT>
        <NAME>NEO-PO-Vitamin E Drops</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>D10W</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>NEO-IV-Gentamicin</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Chloride</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
    </POEEVENTS>
    <LABEVENTS>
      <EVENT>
        <NAME>Indirect bilirubin Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Monocytes per 100 leukocytes in Cerebral spinal fluid</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sodium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lymphocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Indirect bilirubin Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Chloride Moles per volume in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes  per volume in Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular volume Entitic volume</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hemoglobin Mass per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ovalocytes Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Myelocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anisocytosis Presence in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
    </LABEVENTS>
    <NOTEEVENT>
      <CAREUNIT>NICU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>npn 1900-0700</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>GI/GU: Abd soft, +BS. ? future CABG for treatment of moderately diseased RCA given DM. Pt also w/ some adrenal insufficiency. Retroperitoneal fluid as described above. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>NICU</CAREUNIT>
      <CAREGIVER>RN3</CAREGIVER>
      <TITLE>NPN 11p-7a</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Sats 98% on vent/cpap with peep 5, PS 14, 30%Fi02. + GENERALIZED EDEMA, LUE CONTINUALLY WEEPING SEROUS FLUID. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>NICU</CAREUNIT>
      <CAREGIVER>RRT9</CAREGIVER>
      <TITLE>NPN 07-1900</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>drinking well persuaded to take some soup and pears at lunch time insulin drip on until 1330 given 2 units s/c repeat bs 185. O2 sat 92-95%. WILL KEEP INTUBATED UNTIL TOMRROW PM. HOSPITAL COURSE: The Liver Service was consulted, because the patient has undergone a liver transplant six years ago for alcohol induced cirrhosis. Received first dose Tacrolimus. ALTERED CARDIAC STATUS:  PROCEDURE/FINDINGS: The procedure was performed by Drs. Tylenol x 2. Discharge Instructions: Soft solid diet for two weeks. Findings suggest segmental occulusion of this vessel. Denies Nausea. Per the pt's wife, he does occasionally experience transient word-finding difficulty which seemed more pronounced yesterday. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>NICU</CAREUNIT>
      <CAREGIVER>RN3</CAREGIVER>
      <TITLE>Neonatology Attending Note</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Otherwise there is no evidence of obstruction. Has not been hypotensive since arrival. leg jp. rt. leg jp site reinforced w pressure dsg by m.d. &amp; re aced. Left retrocardiac pneumonia. Pt has not had any further episodes of chest pain in-house. The line was then aspirated, flushed, capped, and heplocked. His last drink was five days prior to admission. CV: BP labile. Extremities warm with palpable periferal pulses. Pupils 2mm brisk. There is slight mucosal thickening in the right maxillary sinus. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>NICU</CAREUNIT>
      <CAREGIVER>NP0</CAREGIVER>
      <TITLE>Nursing Progress Note</TITLE>
      <CATEGORY>MD Notes</CATEGORY>
      <TEXT>IMPRESSION: 1. Improving congestive heart failure. 2. Continuing left lower lobe pneumonia. Pupils 2mm brisk. Pt was afebrile at OSH and VSS with SBPs in the 80s-90s systolic. MRA TECHNIQUE: 3D time-of-flight MRA of the head. Foley in patent w/ adequate uo. AS PER ORDERS. mae to commands. conversing talking about pain in back and hip, given tylenol 650 mgs po for pain and shortly after became difficult to rouse . There were no immediate post-procedure complications. Foley patent - clear/yellow urine &gt;30 cc/hr. Patent right hepatic artery. Weaned off NRB to humidified shovel mask 70% to 40% this afternoon w/ 4L N/C. Lopressor doses held per team. PT COMPLAINING OF ABDOMINAL/INCISIONAL PAIN, TEAM AWARE AND FENT GTT INCREASED TO 150 MCG. Foley in place w/ uo &gt; 30 cc/hr. There is no JVD. If the right- sided diffuse density on the base is a result of posteriorly located pleural effusion in the supine patient </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>NICU</CAREUNIT>
      <CAREGIVER>RN8</CAREGIVER>
      <TITLE>NPN 11p-7a</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Given Albuterol nebs x 2 this shift. poor appetite, taking small amts from meals. Levothyroxine Sodium 88 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily). He seemed confused, and did not appear to appropriately respond to what his wife was saying. NEURO:PUPILS 6MM. GU: oliguric MD aware. PLAN: CONTINUE TO CLOSELY MONITOR RESP STATUS. GU/GI: soft distend abd. ? free h2o secondary to increased Na and osmo. Sats were 95-97%. MD's aware. bs with crackles rll, very diminished bs left base. Hepatofugal in the main and right anterior portal veins consistent with underlying portal hypertension. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>NICU</CAREUNIT>
      <CAREGIVER>RN4</CAREGIVER>
      <TITLE>NPN 1900-0700</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Skin has become pink,warm. No deficits. Nonvisualization of the left common femoral artery and proximal superficial femoral artery due to metallic artifact,  Foley patent with adeq UO. The patient continued to show clinical improvement and on postoperative day six was transferred to the regular nursing floor. CRI. TECHNIQUE: Contiguous axial images were obtained from the lung apices through the lung bases and high resolution reconstructions were obtained. It was explaned to pt by staff why she could not have anything (secondary to lethargy for past 24hours requiing mask ventilation) Resp: pt on 2l np still retaining CO2. Some sludge is noted within a mildly distended gallbladder. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>NICU</CAREUNIT>
      <CAREGIVER>RRT6</CAREGIVER>
      <TITLE>PCA Progress Note 1900-700</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>In the Trauma Bay, he received a standard ACLS protocol. Resp: LS clear diminished. FINDINGS: Again seen is a rim enhancing fluid collection in the left parietal lobe with an enhancing peripheral nodule. Vac dsg on left groin intact. COMPARISONS: None. Sats drop when sitting up. abd soft and distended. Neuro: Easily arouse by voice, MAE's except cannot move L toes; following commands consistently;  Based upon the markers on the guide wire, the PICC catheter was then trimmed to a length of 40 cm. CV- SB-SR with occassional PACs. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>NICU</CAREUNIT>
      <CAREGIVER>NP8</CAREGIVER>
      <TITLE>NPN</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>ABDOMEN SOFTLY DISTENDED, + BS. cont with generalized edema. WILL ATTEMPT WEAN AGAIN THIS AM. Heparin 10,000 units given at 2110 per transplant team. copd-home o2 2l. htn. K+ level improved to 4.7 following Kaexylate dose. Plan: wean as tolerate and keep confortable. Will follow. 7a-7p Neuro: Received pt lethargic, easily arousable. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>NICU</CAREUNIT>
      <CAREGIVER>RRT9</CAREGIVER>
      <TITLE>Fellow PE Note</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>required PRN lopressor times 2 for SBP &gt; 165, responded w/ fair results bringing BP down to 155. gen weakness. Await family meeting today.  The pancreas, spleen, stomach, small and large bowel, adrenals and ureters are unremarkable. Con't w/ extention in LE's bilaterally to nipple pinch yet no response with UE's. PT WITH OCCASIONAL PROD COUGH. Pulmonary edema has improved since the prior study. Social: Wife and sister called and spoke to family. A/P- pt neurologically unchanged, family mtg today. Perrla. MAE. o:neuro=initially a/a/o-after fentanly 12.5mcg-very confused/agitated/ @ x's combative. BP 120-140's/50-60's, PAP30-40/15-20 unable to wedge,SICU fellow aware. WEAN VENT &amp; EXTUBATE IN AM  Becomes slightly frustrated d/t expressive aphasia. case management was requested to begin rehab screening. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>NICU</CAREUNIT>
      <CAREGIVER>RRT7</CAREGIVER>
      <TITLE>NNP On-Call</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Still minor paraphasic errors, but much improved. BUTTOCKS WITHOUT BREAKDOWN. Presented with elevated INR. Placed on nonrebreather during episodes of unresolved decreased O2 sats. Since d/c, notes progressive cooling of left foot. required PRN lopressor times 2 for SBP &gt; 165, responded w/ fair results bringing BP down to 155. A slow ooze was visualized from the right tonsillar fossa which was cauterized. The right brachial vein was then accessed using a 21-gauge micropuncture needle. Suctioned for no secretions. </TEXT>
    </NOTEEVENT>
  </ADMISSION>
</DOCUMENT>
<DOCUMENT>
  <ADMISSION>
    <HADM_ID>43</HADM_ID>
    <PATIENT>
      <SUBJECT_ID>940822</SUBJECT_ID>
      <SEX>M</SEX>
      <AGE_AT_ADMISSION>73</AGE_AT_ADMISSION>
      <AGE_AT_ADMISSION_GRP>65+</AGE_AT_ADMISSION_GRP>
      <ADMISSION_DATE>2012-07-03 02:36:37</ADMISSION_DATE>
      <ADMISSION_DATE_YRMON>2012_07</ADMISSION_DATE_YRMON>
      <ADMISSION_DATE_MON_GRP>07</ADMISSION_DATE_MON_GRP>
      <ADMISSION_DATE_DAYMON_GRP>03</ADMISSION_DATE_DAYMON_GRP>
      <ADMISSION_DATE_DAYWEEK_GRP>2-Tue</ADMISSION_DATE_DAYWEEK_GRP>
      <ADMISSION_DATE_WEEK_GRP>27</ADMISSION_DATE_WEEK_GRP>
      <DISCHARGE_DATE>2012-07-05 22:36:37</DISCHARGE_DATE>
      <DOB>1939-03-31</DOB>
      <HOSPITAL_EXPIRE>N</HOSPITAL_EXPIRE>
      <ETHNICITY>WHITE</ETHNICITY>
      <ADMISSION_TYPE>EMERGENCY</ADMISSION_TYPE>
      <RELIGION>CATHOLIC</RELIGION>
      <ADMISSION_SOURCE>EMERGENCY ROOM ADMIT</ADMISSION_SOURCE>
      <OVERALL_PAYOR_GROUP>MEDICARE</OVERALL_PAYOR_GROUP>
      <MARITAL_STATUS>NONE</MARITAL_STATUS>
      <DOD>None</DOD>
      <AGE_AT_DEATH>(N/A)</AGE_AT_DEATH>
      <AGE_AT_DEATH_GRP>(N/A)</AGE_AT_DEATH_GRP>
    </PATIENT>
    <DRG>
      <CODE>329</CODE>
      <ITEMID>60500</ITEMID>
      <DESC>MAJOR SMALL &amp;amp; LARGE BOWEL PROCEDURES W M</DESC>
      <COST_WEIGHT>4.5</COST_WEIGHT>
      <COST_WEIGHT_GRP>4.0-&lt;5.0</COST_WEIGHT_GRP>
      <DISPLAY>(329)MAJOR SMALL &amp;amp; LARGE BOWEL PROCEDURES W M</DISPLAY>
    </DRG>
    <ICD9>(585.6)None</ICD9>
    <ICD9>(518.82)OTHER PULMONARY INSUFFICIENCY NOT ELSEWHERE CLASSI</ICD9>
    <ICD9>(396.3)MITRAL/AORTIC VAL INSUFF</ICD9>
    <ICD9>(V45.81)POSTSURGICAL AORTOCORONARY BYPASS STATUS</ICD9>
    <ICD9>(414.01)CORONARY ATHEROSCLEROSIS OF NATIVE CORONARY ARTERY</ICD9>
    <ICD9>(285.1)AC POSTHEMORRHAG ANEMIA</ICD9>
    <ICD9>(412)OLD MYOCARDIAL INFARCTION</ICD9>
    <ICU>
      <COUNT>1</COUNT>
      <ICU>
        <ICUSTAY_ID>158100</ICUSTAY_ID>
        <FIRST_CAREUNIT>CCU</FIRST_CAREUNIT>
        <LAST_CAREUNIT>CCU</LAST_CAREUNIT>
        <INTIME>2012-07-03 02:36:37</INTIME>
        <OUTTIME>2012-07-05 22:36:37</OUTTIME>
        <LOS>4320</LOS>
        <LOS_GRP>04000-&lt;05000</LOS_GRP>
        <MEDEVENTS>
          <EVENT>
            <NAME>Vasopressin</NAME>
            <OCCURRENCES>30</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Nitroglycerine-k</NAME>
            <OCCURRENCES>7</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Propofol</NAME>
            <OCCURRENCES>5</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Fentanyl</NAME>
            <OCCURRENCES>10</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Nitroprusside</NAME>
            <OCCURRENCES>1</OCCURRENCES>
          </EVENT>
        </MEDEVENTS>
      </ICU>
    </ICU>
    <POEEVENTS>
      <EVENT>
        <NAME>Meperidine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Captopril</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ipratropium Bromide MDI</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Metoprolol</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Diltiazem Extended-Release</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ondansetron</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Carbidopa-Levodopa 25-100</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Docusate Sodium</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>NS</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>NS Glass Bottle</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Oxycodone-Acetaminophen</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Iso-Osmotic Sodium Chloride</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Phenytoin</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>D5W</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Acetaminophen</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bisacodyl</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Nitroglycerin SL</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Fentanyl Citrate</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Metoprolol Tartrate</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Doxycycline Hyclate</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>sodium bi</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Morphine Sulfate</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Spironolactone</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Famotidine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Metoprolol</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Albuterol 0.083 percent Neb Soln</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Vancomycin HCl</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>PNEUMOcoccal Vac Polyvalent</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Miconazole Powder 2 percent</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>NS Mini Bag Plus</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>NS</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Aluminum-Magnesium Hydrox.-Simethicone</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Furosemide</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Cefazolin</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Phosphate</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Midazolam</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Silver Nitrate Applicator</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
    </POEEVENTS>
    <LABEVENTS>
      <EVENT>
        <NAME>Oxygen per Inspired gas setting Volume Fraction Ventilator</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes Presence in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Prothrombin time PT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Calcium oxalate crystals Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hematocrit Volume Fraction of Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Triglyceride Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sodium Moles per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Urea nitrogen Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Nitrite Presence in Urine by Test strip</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Calcium Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sodium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Troponin I.cardiac Mass per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Cortisol Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Magnesium Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Alkaline phosphatase Enzymatic activity per volume in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Platelets  per volume in Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Macrocytes Presence in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Serum</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Transitional cells  per area in Urine sediment by Microscopy high power field</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Microcytes Presence in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular volume Entitic volume</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Phosphate Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Urea nitrogen Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Prothrombin time PT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Myelocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Nitrite Presence in Urine by Test strip</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
    </LABEVENTS>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RN9</CAREGIVER>
      <TITLE>focus update note</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Non-ionic contrast was used due to patient debility. CV: Hemodynamically stable. There is no significant adjacent T2 signal abnormality that is not attributable to the hemorrhage. The line is ready for use. reported to MD. He landed on his head suffering severe closed head injury. Requiring 6L NC and 40% face tent for sats of 94-95%. No intravenous or oral contrast was used. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RRT8</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Given gentamycin and vanco. UNABLE TO GIVE PERI-OP DOSE OF LOPRESSOR DUE TO LOW BP- DISCUSSED WITH DR. Continues to experience reoccurring CP(left sided) associated w/ deep breathing. There is no hydronephrosis. PAIN: PT.GIVEN 650 PO ACETAMINOPHEN FOR PAIN. HIS BELLY "HURTS" AND "I FEEL LIKE I HAVE TO PEE. RESP: ls clear with dim bases. cont with generalized edema. Comparison would need to be obtained with the outside MRI to determine whether the amount of peripheral enhancement has increased. GI/GU: +BS/FLATUS, NO BM, NO N/V. Physical Exam: Intubated and sedated Nose: rapid rhino pack in both nares Oropharynx: copious blood clots. encouraged to eat. The posterior tibial artery occludes at the level of the ankle. No enhancing nodules are identified. CV: NSR-NO ECTOPY. 5 mg bid for 5 days and then to take 1. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>FICU</CAREUNIT>
      <CAREGIVER>RRT1</CAREGIVER>
      <TITLE>Resp Care</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>Foley patent - clear/yellow urine &gt;30 cc/hr. No evidence of pneumonia. No adventitious movements noted. The patient was followed by the Social Service for multiple social issues. ABD SOFT. +BS. Pulses present by doppler PT remain difficult to find but DP easily found. There is no evidence of pneumothorax. Family in to visit patient, in room for approx. FINDINGS: There are no aneurysms. CONDITION UPDATED POST-OP DAY #1 CAUTERIZATION FOR TONSILLER BLEED PLEASE REFER TO CAREVU FOR DETAIL INFO;  There is cardiomegaly with slighlty prominent pulmonary vascularity consistent with improving congestive heart failure. Continue to follow and begin NPH o  Increased generalized edema, L arm +2 edema. 4L-NC - &gt;95%. 20MG IV LASIX GIVEN X2 WITH GOOD DIURESIS. </TEXT>
    </NOTEEVENT>
  </ADMISSION>
</DOCUMENT>
<DOCUMENT>
  <ADMISSION>
    <HADM_ID>44</HADM_ID>
    <PATIENT>
      <SUBJECT_ID>360565</SUBJECT_ID>
      <SEX>M</SEX>
      <AGE_AT_ADMISSION>63</AGE_AT_ADMISSION>
      <AGE_AT_ADMISSION_GRP>35-64</AGE_AT_ADMISSION_GRP>
      <ADMISSION_DATE>2011-10-06 12:18:42</ADMISSION_DATE>
      <ADMISSION_DATE_YRMON>2011_10</ADMISSION_DATE_YRMON>
      <ADMISSION_DATE_MON_GRP>10</ADMISSION_DATE_MON_GRP>
      <ADMISSION_DATE_DAYMON_GRP>06</ADMISSION_DATE_DAYMON_GRP>
      <ADMISSION_DATE_DAYWEEK_GRP>4-Thu</ADMISSION_DATE_DAYWEEK_GRP>
      <ADMISSION_DATE_WEEK_GRP>40</ADMISSION_DATE_WEEK_GRP>
      <DISCHARGE_DATE>2011-11-22 06:18:42</DISCHARGE_DATE>
      <DOB>1948-10-02</DOB>
      <HOSPITAL_EXPIRE>Y</HOSPITAL_EXPIRE>
      <ETHNICITY>BLACK/AFRICAN AMERICAN</ETHNICITY>
      <ADMISSION_TYPE>EMERGENCY</ADMISSION_TYPE>
      <RELIGION>NOT SPECIFIED</RELIGION>
      <ADMISSION_SOURCE>EMERGENCY ROOM ADMIT</ADMISSION_SOURCE>
      <OVERALL_PAYOR_GROUP>MEDICARE</OVERALL_PAYOR_GROUP>
      <MARITAL_STATUS>MARRIED</MARITAL_STATUS>
      <DOD>2011-11-22 06:18:42</DOD>
      <AGE_AT_DEATH>63</AGE_AT_DEATH>
      <AGE_AT_DEATH_GRP>35-64</AGE_AT_DEATH_GRP>
    </PATIENT>
    <DRG>
      <CODE>419</CODE>
      <ITEMID>60619</ITEMID>
      <DESC>FEVER OF UNKNOWN ORIGIN AGE &amp;gt;17 WITH CC</DESC>
      <COST_WEIGHT>0.87</COST_WEIGHT>
      <COST_WEIGHT_GRP>0.5-&lt;1.0</COST_WEIGHT_GRP>
      <DISPLAY>(419)FEVER OF UNKNOWN ORIGIN AGE &amp;gt;17 WITH CC</DISPLAY>
    </DRG>
    <ICD9>(731.8)OTHER BONE INVOLVEMENT IN DISEASES CLASSIFIED ELSE</ICD9>
    <ICD9>(410.11)AMI OTHER ANT WALL INIT</ICD9>
    <ICD9>(926.19)CRUSHING INJURY OF OTHER SPECIFIED SITES OF TRUNK</ICD9>
    <ICD9>(599.0)URINARY TRACT INFECTION SITE NOT SPECIFIED</ICD9>
    <ICD9>(414.01)CORONARY ATHEROSCLEROSIS OF NATIVE CORONARY ARTERY</ICD9>
    <ICD9>(570)ACUTE NECROSIS OF LIVER</ICD9>
    <ICD9>(788.20)RETENTION OF URINE UNSPECIFIED</ICD9>
    <ICD9>(585.6)None</ICD9>
    <ICD9>(410.91)ACUTE MYOCARDIAL INFARCTION OF UNSPECIFIED SITE IN</ICD9>
    <ICU>
      <COUNT>1</COUNT>
      <ICU>
        <ICUSTAY_ID>741658</ICUSTAY_ID>
        <FIRST_CAREUNIT>CCU</FIRST_CAREUNIT>
        <LAST_CAREUNIT>CCU</LAST_CAREUNIT>
        <INTIME>2011-10-06 12:18:42</INTIME>
        <OUTTIME>2011-11-22 06:18:42</OUTTIME>
        <LOS>67680</LOS>
        <LOS_GRP>50000+</LOS_GRP>
        <MEDEVENTS>
          <EVENT>
            <NAME>Fentanyl</NAME>
            <OCCURRENCES>139</OCCURRENCES>
          </EVENT>
        </MEDEVENTS>
      </ICU>
    </ICU>
    <POEEVENTS>
      <EVENT>
        <NAME>Sodium Chloride</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lorazepam</NAME>
        <OCCURRENCES>16</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Isosorbide Dinitrate</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Metronidazole</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Atropine Sulfate</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Albuterol Neb Soln</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>NS</NAME>
        <OCCURRENCES>54</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Clopidogrel Bisulfate</NAME>
        <OCCURRENCES>20</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Morphine Sulfate</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ceftriaxone</NAME>
        <OCCURRENCES>12</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ipratropium Bromide Neb</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Syringe IV Room</NAME>
        <OCCURRENCES>10</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Heparin</NAME>
        <OCCURRENCES>24</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ferric Gluconate</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Oxycodone-Acetaminophen</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Phenylephrine HCl</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Famotidine</NAME>
        <OCCURRENCES>16</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ketorolac</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Haloperidol</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>LR</NAME>
        <OCCURRENCES>17</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Morphine Sulfate Oral Soln.</NAME>
        <OCCURRENCES>16</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Nystatin Oral Suspension</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Metronidazole</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ranitidine</NAME>
        <OCCURRENCES>10</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lorazepam</NAME>
        <OCCURRENCES>10</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Nitroglycerin</NAME>
        <OCCURRENCES>10</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>None</NAME>
        <OCCURRENCES>15</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Promethazine HCl</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Oxycodone</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
    </POEEVENTS>
    <LABEVENTS>
      <EVENT>
        <NAME>Albumin Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Transferrin Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular hemoglobin Entitic mass</NAME>
        <OCCURRENCES>59</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Polychromasia Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Polychromasia Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>12</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anisocytosis Presence in Blood</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatine kinase.MB Mass per volume in Blood</NAME>
        <OCCURRENCES>77</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Acetaminophen Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Serum</NAME>
        <OCCURRENCES>51</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Oxygen per Inspired gas setting Volume Fraction Ventilator</NAME>
        <OCCURRENCES>56</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Oxygen.alveolar - arterial Partial pressure Respiratory system</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Chloride Moles per volume in Blood</NAME>
        <OCCURRENCES>47</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Triacylglycerol lipase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>16</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Epithelial cells  per area in Urine sediment by Microscopy high power field</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Specific gravity of Urine by Test strip</NAME>
        <OCCURRENCES>31</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte distribution width Ratio</NAME>
        <OCCURRENCES>52</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Specific gravity of Urine by Test strip</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Basophils per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>28</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Calcium.ionized Moles per volume in Blood</NAME>
        <OCCURRENCES>16</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Magnesium Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>57</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Calcium Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>53</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sodium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>85</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lymphocytes Variant per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>12</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bilirubin Presence in Urine</NAME>
        <OCCURRENCES>24</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Platelets  per volume in Blood</NAME>
        <OCCURRENCES>47</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Microcytes Presence in Blood</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Platelets  per volume in Blood</NAME>
        <OCCURRENCES>52</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Magnesium Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>56</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes  per volume in Blood</NAME>
        <OCCURRENCES>63</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatine kinase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>47</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lactate Moles per volume in Blood</NAME>
        <OCCURRENCES>39</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Specific gravity of Urine by Test strip</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Specific gravity of Urine by Test strip</NAME>
        <OCCURRENCES>16</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ammonia Moles per volume in Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Natriuretic peptide.B prohormone Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Metamyelocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Chloride Moles per volume in Blood</NAME>
        <OCCURRENCES>72</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>70</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>INR in Blood by Coagulation assay</NAME>
        <OCCURRENCES>26</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte distribution width Ratio</NAME>
        <OCCURRENCES>49</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Urobilinogen Mass per volume in Urine</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Cholesterol.total per Cholesterol.in HDL Molar ratio in Serum or Plasma</NAME>
        <OCCURRENCES>16</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Moles per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sodium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>47</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Urobilinogen Mass per volume in Urine</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Phosphate Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>47</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatine kinase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Aspartate aminotransferase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Magnesium Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>40</OCCURRENCES>
      </EVENT>
    </LABEVENTS>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Palpable pulses bilaterally. IMPRESSION: Successful placement of a 40 cm long single lumen PICC via the right brachial vein with the tip terminating in the SVC. CV; SB/NSR with rare PVC. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CCU</CAREUNIT>
      <CAREGIVER>RN1</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT></TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RN9</CAREGIVER>
      <TITLE>T/SICU NSG NOTE</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Plan: Continue cardiopulmonary monitoring. GUAIAC NEGATIVE. No c/o SOB or dyspnea noted. The patient was placed supine on the angiography table. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>TLS cleared-logroll dc'd. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>C02 51 (down from 66). There is no significant midline shift. NO VEA OBSERVED. MSO4 given at 2100 and 2140 5mg each dose. expectorated good amt sputum for culture this evening post ultrasonic neb treatment. GU; VOIDING GOOD AMOUNTS . A final chest radiograph confirmed placement of the tip of the catheter to be in the superior vena cava. GI/GU: foley patent. A/P- pt neurologically unchanged, family mtg today. Hct dropped, 2 ux of PRBC's were given, 2nd ux finished soon after arrival. ENDO: SSRI FS qid. Tylenol given for general aches. SOCIAL;" WIFE INTO VISIT AND STATES PT GETS SLIGHTLY FORGETFUL AND AGITATED AT HOME . BS at 0230 110. Palpable pulses bilaterally DP/PT +2/+1. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>RN0</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>PACER A DEMAND A WIRES DO NOT CAPTURE 100% OF THE TIME, SENSING, V WIRES OFF THEY DO SENSE AND CAPTURE APPROPRIATELY. No c/o pain. ABD distended with Absent BS. Pt O2 sat difficult to obtain at times. wo co sob/ dyspnea. Levothyroxine Sodium 88 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily). There is periventricular white matter digitiform hypodensity, significantly worse on the left, suggestive of persistent tumor-related. NBP 83-112/47-77. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>MICU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>In the Trauma Bay, he received a standard ACLS protocol. O2 Sat 96%. RESP 20-22 WITH SHALLOW BREATHING. Endocrine: requiring sliding scale insulin. K NL. ALTERED CARDIAC STATUS:  Her left foot will ensuingly becomes numb and painful. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>RN0</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT></TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RN1</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>11P-7A NEURO: alert and oriented x3. IMPRESSION: Normal brain MRA. CLAMPED MOST OF THE NIGHT FOR MEDS. See written note in papaer chart, carevu down  </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CCU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>CONDITION UPDATE:</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>No indwelling tubes are identified and no pneumothorax is present. IMPRESSION: 1. Layering right pleural effusions. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RN3</CAREGIVER>
      <TITLE>STATUS</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>Per wife reports pt w hx of confusion/agitation when not on psych meds(paxil&amp; klonopin). No BM this shift. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>Respiratory care:</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Has uses prn Sl NTG for these episodes with resolution of symptoms. Vascular calcifications are seen in the aorta, IVC, splenic and renal arteries. No surrounding hemorrhage or mass effect. CONTINUES WITH A CHEST TUBE LEAK. Activity: Bedrest d/t resp. status. PROCEDURE/FINDINGS: The procedure was performed by Drs. Pt also w/ some adrenal insufficiency. Diffusion-weighted imaging was also obtained. htn better controlled w ^ lopressor to 50 bid. Pulmonary to follow up in am. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>Pt's BP was 90-100. 6U PRBC ON HOLD FOR OR. GIVEN MOM AT 1640. K+ continues to be elevated, EKG remains unchanged. Pt breathing appeared somewhat labored. Vascular calcifications are seen in the aorta, IVC, splenic and renal arteries. FAMILY ALSO NOTICED INCREASED ABD GIRTH OVER THE PAST FEW WEEKS. He cannot repeat nor name, read, or write. Hard copy pre- and post-puncture images by ultrasound were obtained. Monitor per protocol. Coronal reformations were also obtained and reviewed. Findings suggest segmental occulusion of this vessel. There is atelectasis within the basal portion of the left lower lobe which causes obscuration of the left hemidiaphragm. Mediastinum has normal contour and width. There is left retrocardiac density which could represent atelectasis and/or pneumonia. IV therapy failed. Neuro: Pt sedated, presently on propofol 100cmg/kg/min and fentanyl 100mcg/hr. ALLERGIES: Talwin and Codeine, manifestations unknown. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>T-SICU</CAREUNIT>
      <CAREGIVER>RN9</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>HOSPITAL COURSE: The Liver Service was consulted, because the patient has undergone a liver transplant six years ago for alcohol induced cirrhosis. see above note. c/o chest pain nitro given without relief, EKG WNL. IMPRESSION: Status post catheter device placement within the left parietal cystic structure. Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig: One (1) Disk with Device Inhalation BID (2 times a day). therefore, patency of the distal dorsalis pedis artery within the foot cannot be assessed. Past Medical History: Gout  bs with crackles rll, very diminished bs left base. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Transparent dressing currently in place. BUN/CR 58/3.0. TECHNIQUE: Non-contrast head CT. Limited views of the right kidney demonstrate no hydronephrosis. post transfusion HCT 33. 8GIVEN PR TYLENOL AT 8AM,FAN ON. Some ankle edema noted. Tolerated very well. MOVES LOWER JAW WITH INSERTION OF TEMP PROBE. IMPRESSION: Successful placement of a 40 cm long single lumen PICC via the right brachial vein with the tip terminating in the SVC. Currently on 750mg BID and will d/c with insturctions to increase to 1000 BID starting monday and taper dilantin by 100mg every week for 3 weeks until discontinued. Follow up as soon as possible with Dr. DISCHARGE DIAGNOSES: 1. Unstable angina. A limited renal ultrasound was performed at bedside. No evidence of pneumonia. Had two day c/o abd pain. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>FICU</CAREUNIT>
      <CAREGIVER>RN2</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>RSBI=40 this am. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>FICU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>INCREASE ACTIVITY. Follow labs. REASON FOR THIS EXAMINATION: Please evaluate for infection   LUMGS CLEAR/COARSE BILAT. TECHNIQUE: Contiguous axial images of the abdomen and pelvis were obtained without IV or oral contrast. Discharge Condition: good  He was found to be in asystole. + dopplerable DP bilat, + dopplerable PT bilat though difficult to find and weak, no change from earlier assessment. NEURO: LETHARGIC, ORIENTED X2, FOLLOWING COMMANDS. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>FICU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>NURSING NOTE</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>ABDOMINAL US: 1.Diffuse fatty infiltration of the liver. therefore, patency of the distal dorsalis pedis artery within the foot cannot be assessed. BLOOD PRESSURE MEASURE DIFFERENCE BETWEEN ARTERIAL LINE AND BLOOD PRESSURE CUFF-&gt; ARTERIAL PRESSURE APPROXIMATELY 20-30 POINTS HIGHER THAN CUFF PRESSURE. Medications on Admission: keflex roxicet indomethacin  last tx at 5 am pt inc. more crackles. OOB to chair. No BM this shift. The line was then secured to the skin with a StatLock device and a sterile transparent dressing applied. Carcinoma of right tonsil as above  No definite pleural effusion is seen. pt sister called no other family members contacted. FINAL REPORT HISTORY: 64-year-old man with a left temporal astrocytoma. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>RRT9</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>CV- Hypertensive in am and labetolol gtt restarted. Treated with Albuterol and Atrovent nebs with minimal effect. allergies:ace inhibitors. transdermal ntg. Clonidine TTS #1 patch q Wednesday,  will cont to monitor uop closely. BP 120-140's/50-60's, PAP30-40/15-20 unable to wedge,SICU fellow aware. bbs clear ^ lobes &amp; rt bases w crackles. cvs tmax 97. OMR note of several episodes of rest pain of unclear etiology (? vasospasm) post cath and prior to d/c on last admit. No prior MRIs are available at this institution. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>NPN 7p-7a</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>NEURO: ORALLY INTUBATED, LIGHTLY SEDATED ON PROPOFOL GTT AT 20MCG/KG. LLL infiltrate&gt; worstening pna, atelectasis. Blood loss anemia corrected. +gag, + cough. 5mg daily from there. Family appears to be very supportive of each other and continue to cope well under extreme stress. ?CHF. Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig: One (1) Disk with Device Inhalation BID (2 times a day). ?CHF. R groin intact. He remained hemodynamically stable. c/o chest pain nitro given without relief, EKG WNL. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>RN2</CAREGIVER>
      <TITLE>Nursing Note 7a-7p</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>Left lower lobe collapse/consolidation noted. Per the pt's wife, he does occasionally experience transient word-finding difficulty which seemed more pronounced yesterday. cxr shows pos infiltrate inrt lobes. COMPARISON: Stereotactic head CT from three hours prior. GU: urine ouput 30-40cc/hr. No ectopy. EKG obtained - no change from previous EKG. A--UNSTABLE ABD REQUIRING SURGERY. Local anesthesia was achieved with subcutaneous injection of 2 cc of 1% lidocaine. He had a massive left subdural with massive ventricular obliteration and midline shift. The mediastinum is unremarkable. Findings communicated to the clinical service caring for the patient. LS CTA diminished in lower lobes. pulses dopperable. stating that it does not itch nearly as bad. Aggressive chest pt q 4hrs. Review of system: Code status is now DNR Neuro: AAOx3, difficult at times w/ coming up w/ some words. MAE. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RN9</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Plan: monitor Bp ABG's encourage pt to cough and deep breath . Denies Nausea. He was agonal and unresponsive on the scene with adequate blood pressures. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RN7</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Continue nutrition/ advance feeds by 10ml every 6 hours to goal 80ml. GI--AS ABOVE, NO STOOL. No acute traumatic abnormality identified. Had no associated N/V, diaph, SOB. Serun sodium, osmo and chloride elevated over night , mannitol held and NS infusin cut back KVO. The gallbladder, pancreas, spleen, adrenal glands, kidneys, small bowel, and colon are unremarkable. Pt improved slightly then tmax of 100.7. UNABLE TO PLACE PERIPHERAL ACCESS THEREFORE CENTRAL ACCESS LEFT IN PLACE. K repleted. ABLE TO SPEAK IN SENTANCES,SLOW SPEECH. Resp: 02 sat continues to be at 85-91% on 6l n/p and 100% face tent. 8GIVEN PR TYLENOL AT 8AM,FAN ON. Respirations 30. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RRT4</CAREGIVER>
      <TITLE>npn 7-7pm</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>DC'd at 0300. NEURO:PUPILS 6MM. bs with crackles rll, very diminished bs left base. HYDRALAZINE 10MG IV GIVEN AND TOLERATED WITH DECREASE IN SBP. RR 12-18. HO aware, will evaluate. He underwent a cardiac catheterization, which demonstrated three vessel disease. Will follow. GU--FOLEY CATH PATENT DRAINING BROWN URINE ~10CC HR. +prod cough for tannish thick sputum. CV: Tmax 99.3, HR 55-70 NSR with occasional PVC when sleeping. No evidence of hemorrhage or new lesions. Neuro: Rec'd patient agitated, unresponsive to orientation questions. MRA TECHNIQUE: 3D time-of-flight MRA of the head. Pt breathing appeared somewhat labored. UNABLE TO PLACE PERIPHERAL ACCESS THEREFORE CENTRAL ACCESS LEFT IN PLACE. He has history of PE and DVT post-op and will need to resume anticoagulation (lovenox) in 4-6 weeks. There is bilateral jerk nystagmus in all directions of gaze. IV therapy failed. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RN0</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>CV: PT. NSR, RARE PVC'S, HR BETWEEN 90-108, SBP 95- 115, 5MG IV LOPRESSOR GIVEN ONCE FOR RATE CONTROL. ?COPD d/t extensive hx pf tobacco use. resp; on and off bibap retaining co2. Adeq bp. No stool this shift. Monitor U/O. episode passed, HO aware. No evidence for intestinal obstruction. NURSING ADMIT TO CCU NOTE PT is 56 yr.old male with history DM, heroin abuse on methadone maintenance,  Patient presented to OSH 1 day ago. PTCA and stent x4 to LAD, (80% mRCA not intervened at this time) c/b dissection in distal LAD. 5 L of fluid, epi iv, and monitored overnight on floor. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>LEFT leg: The left common femoral artery and proximal aspect of the superficial femoral artery on the left are partially obscured due to artifact from left hip metallic prosthesis. see flow sheet. OOB to chair. When awake Bp&gt;100. resp status: bbs clear but diminish bibas. TFs off and OGT flushed. Resp: Lungs coarse. TFs changed to full stregnth and rate now advanced to 40cc/h, low residuals. Atenolol 50 mg Tablet Sig: One (1) Tablet PO twice a day. Medicated w/ tylenol for back and left groin pain, w/ relief also repositioned q 2 hours for back relief. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>STATUS</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>no insulin required at present. Does not note a buldge in her inguinum, nor necorosis. HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in oropharynx Neck: supple, no JVD or carotid bruits appreciated. Palpable pulses bilaterally DP/PT +2/+1. PERRL 2mm, brisk CV: SR/ST 70's-110's, occasional PVC's, lytes WNL; afebrile; SBP 80's-130's,  stress dose steroid given, benadryl given. 20MG IV LASIX GIVEN X2 WITH GOOD DIURESIS. ABG WNL. to monitor hemo/resp status. The mediastinal and hilar contours are normal. Acetaminophen 325 to 650 mg q 4 to 6 hours prn for pain.Tacrolimus 3 mg q.a.m.and q.p.m. conversing talking about pain in back and hip, given tylenol 650 mgs po for pain and shortly after became difficult to rouse . IMPRESSION: LV enlargement and possible improving left heart failure. last tx at 5 am pt inc. more crackles. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RN9</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>SW follow while on unit. Admitting Diagnosis: INTRAPARENCHYMAL BLEED  FINAL REPORT (Cont)  There is no significant adjacent T2 signal abnormality that is not attributable to the hemorrhage. Will continue to follow closely. PT NOW SLEEPING SOUNDLY, COMPLAINS OF PAIN DURING MOVEMENT. knee surgeries. 4 units FFP given. WIFE IS HEALTH CARE PROXY Social: Wife and sister called and spoke to family. HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in oropharynx Neck: supple, no JVD or carotid bruits appreciated. RESP: lungs clear o2 at 4l via N/C o2 sats &gt;95%. Resp: lungs dim in bases, on 2 liters nc satting at 96%. CV: PT. NSR, RARE TO OCCASIONAL PVC'S,  </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>DISCHARGE_SUMMARY</CATEGORY>
      <TEXT>Diffusion-weighted imaging was also obtained. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>7am-7pm update</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>see flow sheet. srong productive cough able to use yankeur to remove thick yellow secretions when awake. pos gag. pt given NS bolus 500cc x 2 through night with improvement each time. GI: TOLERATING IMPACT WITH FIBER TUBE FEED ADVANCEMENT, NO RESIDUALS, OGT PLACEMENT CHECKED Q4H. Several smaller lymph nodes are noted in the AP window and precarinal regions. The patient was placed supine on the angiography table. id=afebrile. Plan: Extubate after cuff leak confirmed. ABD became firm and distended. GI/Endo: Start feeds via OGT, tolerated well, abd distended, hypoactive bowel sounds. The line is ready for use. Pt. FINDINGS: There are no aneurysms. He became asystolic at 9:55, and remained asystolic for a total of five minutes confirming the criteria that were met for proceeding with a donation after cardiac death. bp 103/54-160/50 . ? future CABG for treatment of moderately diseased RCA given DM. The osseous structures show degenerative change of the spine. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>MICU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>11p-7a</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Several hours later, pressures drop from SBP of 140s to 90 for period of 30 minutes or so. A: STABLE, REQUIRING INSULIN AND PULM TOILET  This contains a few air bronchograms. PULSES DOPPLERABLE AND WEAK PALPABLE. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>FICU</CAREUNIT>
      <CAREGIVER>RRT2</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>No free air or free fluid is present within the abdomen or pelvis. RESP: ls clear with dim bases. Skin- intact on backside. Palate elevates symmetrically. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>Respiratory Care</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>Monitor resp. status. The heart size is within normal limits. There is atelectasis within the basal portion of the left lower lobe which causes obscuration of the left hemidiaphragm. PLAN: CONT TO ASSESS NEURO, HEMODYNAMIC MONITORING, PAIN MGMT, FAMILY/EMOTIONAL SUPPORT. MAE, right upper and lower extremities stronger than left side. returned from ct scan pt initally aoox3 c/o of severe back pain then became increasingly somulent  Family aware of potential for second family meeting today to address plan of care. Pt pulling at cpap mask at times stating she can't breathe. The pt had been in his usual state of health until this morning at roughly 8am. IMPRESSION: Persistent left lower lobe atelectasis/infiltrate, increased evidence of left-sided pleural effusion. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>DISCHARGE_SUMMARY</CATEGORY>
      <TEXT>Neuro signs qH. SWAN DC'D CI&lt;2. Atelectasis&amp; worstening pna. IMPRESSION: Normal right kidney. Otherwise there is no evidence of obstruction. He apparently experienced an episode of aphasia and a seizure. Outside hospital CT scan reports possible bleed in the surgical bed. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>FICU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>No prior MRIs are available at this institution. There is no abnormal signal deep to the region of enhancement. ? dophoff placement. BIPAP on standby as needed per ABG. AP UPRIGHT CHEST RADIOGRAPH: There has been interval removal of the right IJ Swan-Ganz catheter, and in it's place is a triple-lumen catheter with it'st tip in the mid SVC. Gtt increased as patient biting on ETT, restless. Major Surgical or Invasive Procedure: MRI/MRA repeat MRI/MRA Femoral line. He was found to have a sodium of 106. RR 16-22. We arec sxtn for scant to minimal secrettions fro ETT. TX W/ 10 UNITS OF REG INSULIN, 1 AMP OF D50 &amp; 30 GMS K+EXOLATE. Discussed with housestaff. O2 decreased to 1Lnc 7.28/56/61. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RN7</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>Sats 91-95% on O2 4L n/c only. JP:Draining 40cc bloody drg. Echo done at bedside this am. and benadryl 25 mgs i.v. FINAL REPORT INDICATION: Hypoxia. Local anesthesia was achieved with subcutaneous injection of 2 cc of 1% lidocaine. cvs; tmax 98 po nsr 135-145/57 given lopressor 25 mgs po at 10 am to bring dose up to 75 mgs po bid. Cont on levoflox Q24hrs. COMPARISONS: None. A family meeting that day with Dr. ON MANNITOL GI:STARTED TF AT 10CC HR,+ BS. INTEG: PT TURNS/RP INDEPENDENTLY, NO AREAS SKIN BREAKDOWN NOTED. Decadron 0.75 mg Tablet Sig: Two (2) Tablet PO twice a day: take 2 tabs twice a day for the first 5 days, then decrease to 2 tabs once a day from there. Suctioned for moderate amounts thick, pale yellow mucus. Resp: 02 sat continues to be at 85-91% on 6l n/p and 100% face tent. no bm. allergies:ace inhibitors. transdermal ntg. HR=70-80's NSR, no ectopy. Calcification of the coronary arteries is present. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>PT HAS NO BONE ON L SIDE OF HEAD. GI: TOLERATING IMPACT WITH FIBER TUBE FEED ADVANCEMENT, NO RESIDUALS, OGT PLACEMENT CHECKED Q4H. Perrla. MAE. Comparison would need to be obtained with the outside MRI to determine whether the amount of peripheral enhancement has increased. Decision to withdraw support and organ donation by family in accordance with known wishes of pt. Physical Exam: VS: 97.7, HR 100, BP 117/68, RR 20, O2sat 95% 4LNC  There is magnetic susceptibility from the blood products as well as the clips in the craniotomy site, which obscures some of the image. CONDITION UPDATE ASSESSMENT: PT IS ALERT MOST OF DAY, ORIENTED X3. Desats to low 80s if mask remains off too long. ultrasound of the liver with doppler of the veins, once the patient has left the Coronary Care Unit. continues on nitro gtt at 0.8mcg/kg/min. Platelets 143 (166). Laryngeal penetration is noted with rapid swallows of thin barium, with penetration to the level of the vocal cords. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CCU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>DISCHARGE_SUMMARY</CATEGORY>
      <TEXT>RSBI=40 this am. Preop for brain biopsy. Surgical clips along the medial left knee, with no graft flow identified. Imaging Protocol: gated SPECT. The gallbladder is not visualized. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RN8</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>Denies Nausea. CV: Hemodynamically stable. Next labs to be done at 2100. There is no evidence of focal infiltrate. Pelvic loops of bowel are displaced posteriorly and superior by this large fluid collection. Note is made of stable appearance of the lesion since surgery on serial scans. Oriented x3. The heart size is normal. Med brown guiac negative stool x1. A precarinal lymph node measuring approximately 1 cm in diameter is noted, a nonspecific finding. General, asleep, drowsy, white male. A final chest radiograph confirmed placement of the tip of the catheter to be in the superior vena cava. c/o pain last eve and medicated with tylenol 650 via ogt with good effect. No stool this shift. The posterior tibial artery occludes at the level of the ankle. PAIN: 1 PERCOCET X2 WITH GOOD EFFECT. Wean off O2 as tolerated. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>IMPRESSION: 1) Moderate, reversible defect of the inferior wall. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>FICU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>RESPIRATORY CARE NOTE</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>Endo: BS 105-180s. Pupils fixed, 6mm, non-reactive. Gi/GU Foley to gravity Q.S. Hourly UOP. Resp Care Pt intermittintly wearing bipap t/o shift for hypercarbic resp failure and remains on NIPPV since 3pm. Resting Perfusion images were obtained with Tl-201. Groin C/D/I, no hematoma, palp DP/PT pulses. CV: PT. NSR, RARE TO OCCASIONAL PVC'S,  The line was then aspirated, flushed, capped, and heplocked. There have been no other changes in the two-day interval. Afebrile. Questionable corneals, impaired cough and no gag. PULSES WEAKLY PALPABLE AND DOPPLERABLE. No priors. IMPRESSION: A left temporal lobe subacute hematoma. CARDIAC: SR 80s. NPN 0700-1500; NEURO; AOOX3 MAE TO COMMAND SHAKEY AT TIMES ANXIOUS BUT EASILY REASSURED. abd soft. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>FICU</CAREUNIT>
      <CAREGIVER>RN4</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>PT STATES PAIN RATED AS "3" @ REST, INCREASES WITH MOVEMENT. ? PA LINE TO BE CHANGED TO CENTRAL LINE. Treated with additional 650 mg of Tylenol w/ good effect. Right groin site intact. Cont integrillin until 0600, replete Mg,  POS PULSES BILAT W/ DOPPLER. Sats 99% on 2L NC. VIDEO OROPHARYNGEAL SWALLOW: There is normal oral bolus control. IMPRESSION: 1. This was communicated to Dr.  2. Patchy left-sided opacities consistent with atelectasis or consolidation. Imaging of the organs of the upper abdomen is limited without intravenous contrast. There is evidence of a layering left-sided pleural effusion. The needle was then exchanged for an introducer sheath. A thin artery coursing along the medial aspect of the calf, from the level of the mid calf to the ankle is identified,  r fem site slight ecchymosis. Managing as indicated per RISS. CV: Rate SB 40s-50s but this is baseline, per wife. Urine cx grew ampicillin sensitive enterococcus. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CCU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>Social: Significant other. Poorly palp pedal pulses, cap refill &lt;3s. A final chest radiograph confirmed placement of the tip of the catheter to be in the superior vena cava. Lungs were clean, dry and intact. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>FICU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>NURSING PROGRESS NOTE 1900-2300</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Diffusion-weighted imaging was also obtained. OOB to chair, humidified O2, continued Neb treatments and aggressive chest pt. Dispo: Full Code A/P: OOB to chair tolerated very well with improved O2 sats. Vascular surgery was consulted. Brain perfusion study done in nuclear med which showed flow to R hemisphere. D5 1/2 NS AT 60CC/HR. Tube feeds at goal rate of 80cc/hr FS impact w fiber. There is a bleed on the head CT. K+ remains elevated at 5.9. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>MICU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>C/O NAUSEA @ 1300 DRY HEAVES RECIEVED 10 MG IV REGLAN WITH GOOD EFFECT. No evidence of pneumothorax. Presently HR 70s SR rare pvc and and rare pacs. Slept most of the night. Perrla. MAE. WIFE IS HEALTH CARE PROXY ID- abx's unchanged, pt afebrile. No consolidation is seen. Vascular calcifications are seen in the aorta, IVC, splenic and renal arteries. IMPRESSION: 1. Layering right pleural effusions. After CT done and pt moved to bed from CT table, pt again c/o CP which again resolved on its own. ACCORDING TO WIFE PATIENT IS A 12 PACK PER DAY BEER DRINKER BUT HAS NOT HAD ANYTHING FOR 8 DAYS. FINDINGS: Lung excursion has improved and no focal consolidation is evident. Liver transplant 6yrs ago. Given a total of 2. Please assess Admitting Diagnosis: CONTROL OF TONSILAR BLEED  UNDERLYING MEDICAL CONDITION: 53 year old man intubated at outside hospital. There is appropriate soft palate elevation. Social- Family in and out all day. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>RN0</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>Disp:*300 ML(s)* Refills:*0* 2. Follows commands. MAE- weak. PTCA and stent x4 to LAD, (80% mRCA not intervened at this time) c/b dissection in distal LAD. PT TOLERATING CLEAR LIQUIDS WITHOUT DIFFICULTY. ON OPTIMAL SUPPORT ? ASPIRATION OF BLOOD ( PT HAD SIGNIFICANT HEMOPYTSIS AND VOMITTING. Cut the valsartan dose in half which patient tolerated. Patient can titrate further down to 0.75mg daily if he feels that he can tolerate it. Continues with pulmonary toliet. C/V: vss Heart rate in the 70's-80's with occasional PVC's Aline placed in right wrist by MD cuff on left arm 30 points lower than aline. There is cardiomegaly, unchanged from the prior study. ON MANNITOL Q6HRS ID:T MAX 101. Recently d/c from OSH for pna. 7.36/48/150, see carevu. Resp: Lung coarse/wheezy, getting albuterol neb per RT, on &amp; off BiPAP throughout shift, ABG with BiPAP pH 7.32, pCO2 43; ABG on 2L NC, pH 7. 9 axillary bilaterally x2. Adeq bp. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>No evidence of new hemorrhage or mass effect. sats 88-97%. Bone piece removed from L frontal/parietal area and mod to large bloody drainage from wound. O: CARDIAC: SR 80'S WITHOUT VEA OR PAC'S . ABG AT 0230 SHOWED RESP ACIDOSIS, RATE INCREASED TO 22. </TEXT>
    </NOTEEVENT>
  </ADMISSION>
</DOCUMENT>
<DOCUMENT>
  <ADMISSION>
    <HADM_ID>45</HADM_ID>
    <PATIENT>
      <SUBJECT_ID>155984</SUBJECT_ID>
      <SEX>M</SEX>
      <AGE_AT_ADMISSION>77</AGE_AT_ADMISSION>
      <AGE_AT_ADMISSION_GRP>65+</AGE_AT_ADMISSION_GRP>
      <ADMISSION_DATE>2013-06-29 19:23:50</ADMISSION_DATE>
      <ADMISSION_DATE_YRMON>2013_06</ADMISSION_DATE_YRMON>
      <ADMISSION_DATE_MON_GRP>06</ADMISSION_DATE_MON_GRP>
      <ADMISSION_DATE_DAYMON_GRP>29</ADMISSION_DATE_DAYMON_GRP>
      <ADMISSION_DATE_DAYWEEK_GRP>6-Sat</ADMISSION_DATE_DAYWEEK_GRP>
      <ADMISSION_DATE_WEEK_GRP>25</ADMISSION_DATE_WEEK_GRP>
      <DISCHARGE_DATE>2013-07-03 16:23:50</DISCHARGE_DATE>
      <DOB>1936-07-12</DOB>
      <HOSPITAL_EXPIRE>N</HOSPITAL_EXPIRE>
      <ETHNICITY>UNKNOWN/NOT SPECIFIED</ETHNICITY>
      <ADMISSION_TYPE>EMERGENCY</ADMISSION_TYPE>
      <RELIGION>UNOBTAINABLE</RELIGION>
      <ADMISSION_SOURCE>TRANSFER FROM HOSP/EXTRAM</ADMISSION_SOURCE>
      <OVERALL_PAYOR_GROUP>MEDICARE</OVERALL_PAYOR_GROUP>
      <MARITAL_STATUS>MARRIED</MARITAL_STATUS>
      <DOD>None</DOD>
      <AGE_AT_DEATH>(N/A)</AGE_AT_DEATH>
      <AGE_AT_DEATH_GRP>(N/A)</AGE_AT_DEATH_GRP>
    </PATIENT>
    <DRG>
      <CODE>014</CODE>
      <ITEMID>60024</ITEMID>
      <DESC>INTRACRANIAL HEMORRHAGE &amp;amp; STROKE WITH IN</DESC>
      <COST_WEIGHT>1.24</COST_WEIGHT>
      <COST_WEIGHT_GRP>1.0-&lt;1.3</COST_WEIGHT_GRP>
      <DISPLAY>(014)INTRACRANIAL HEMORRHAGE &amp;amp; STROKE WITH IN</DISPLAY>
    </DRG>
    <ICD9>(414.01)CORONARY ATHEROSCLEROSIS OF NATIVE CORONARY ARTERY</ICD9>
    <ICD9>(285.1)AC POSTHEMORRHAG ANEMIA</ICD9>
    <ICD9>(410.91)ACUTE MYOCARDIAL INFARCTION OF UNSPECIFIED SITE IN</ICD9>
    <ICD9>(424.2)NONRHEUM TRICUSP VAL DIS</ICD9>
    <ICD9>(038.49)OTHER SEPTICEMIA DUE TO GRAM-NEGATIVE ORGANISMS</ICD9>
    <ICD9>(E935.2)OTHER OPIATES AND RELATED NARCOTICS CAUSING ADVERS</ICD9>
    <ICD9>(396.8)MULTIPLE INVOLVEMENT OF MITRAL AND AORTIC VALVES</ICD9>
    <ICU>
      <COUNT>1</COUNT>
      <ICU>
        <ICUSTAY_ID>660002</ICUSTAY_ID>
        <FIRST_CAREUNIT>MICU</FIRST_CAREUNIT>
        <LAST_CAREUNIT>MICU</LAST_CAREUNIT>
        <INTIME>2013-06-29 19:23:50</INTIME>
        <OUTTIME>2013-07-03 16:23:50</OUTTIME>
        <LOS>5760</LOS>
        <LOS_GRP>05000-&lt;07500</LOS_GRP>
        <MEDEVENTS>
          <EVENT>
            <NAME>Neosynephrine-k</NAME>
            <OCCURRENCES>7</OCCURRENCES>
          </EVENT>
        </MEDEVENTS>
      </ICU>
    </ICU>
    <POEEVENTS/>
    <LABEVENTS>
      <EVENT>
        <NAME>Poikilocytosis Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Cholesterol Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Phosphate Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Mucus Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hemoglobin Presence in Urine by Test strip</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bilirubin Presence in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Activated partial thrombplastin time aPTT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ketones Mass per volume in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular hemoglobin Entitic mass</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Platelets  per volume in Blood</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Epithelial cells  per area in Urine sediment by Microscopy high power field</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Nitrite Presence in Urine by Test strip</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Base excess in Blood</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Neutrophils.segmented per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Positive end expiratory pressure setting Ventilator</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatine kinase.MB Mass per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Troponin T.cardiac Mass per volume in Blood</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular hemoglobin concentration Mass per volume</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Neutrophils.segmented per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anion gap in Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Eosinophils per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Alanine aminotransferase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Tidal volume setting Ventilator</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Oxygen Partial pressure in Blood</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Myelocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular hemoglobin concentration Mass per volume</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bacteria Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Serum</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Yeast Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Tidal volume setting Ventilator</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Burr cells Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hypochromia Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sodium Moles per volume in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bilirubin Presence in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Eosinophils per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
    </LABEVENTS>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RN8</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>DISCHARGE_SUMMARY</CATEGORY>
      <TEXT>currently on bipap. with sats 94-95%. PROCEDURE/FINDINGS: The procedure was performed by Drs. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>Will follow. No evidence of hemorrhage or new lesions. reck pending. s/p exp lap for retroperitoneal bleed and fluid shifts. Update O: cv status: sr w rare pvc. Respirations 30. TF at goal w/ no residuals. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>SMICU nsg progress note</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>CV- Hypertensive in am and labetolol gtt restarted. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RN2</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>GUAIAC NEGATIVE. </TEXT>
    </NOTEEVENT>
  </ADMISSION>
</DOCUMENT>
<DOCUMENT>
  <ADMISSION>
    <HADM_ID>46</HADM_ID>
    <PATIENT>
      <SUBJECT_ID>303048</SUBJECT_ID>
      <SEX>F</SEX>
      <AGE_AT_ADMISSION>50</AGE_AT_ADMISSION>
      <AGE_AT_ADMISSION_GRP>35-64</AGE_AT_ADMISSION_GRP>
      <ADMISSION_DATE>2013-08-06 10:28:10</ADMISSION_DATE>
      <ADMISSION_DATE_YRMON>2013_08</ADMISSION_DATE_YRMON>
      <ADMISSION_DATE_MON_GRP>08</ADMISSION_DATE_MON_GRP>
      <ADMISSION_DATE_DAYMON_GRP>06</ADMISSION_DATE_DAYMON_GRP>
      <ADMISSION_DATE_DAYWEEK_GRP>2-Tue</ADMISSION_DATE_DAYWEEK_GRP>
      <ADMISSION_DATE_WEEK_GRP>31</ADMISSION_DATE_WEEK_GRP>
      <DISCHARGE_DATE>2013-08-15 06:28:10</DISCHARGE_DATE>
      <DOB>1963-04-06</DOB>
      <HOSPITAL_EXPIRE>Y</HOSPITAL_EXPIRE>
      <ETHNICITY>HISPANIC/LATINO - PUERTO RICAN</ETHNICITY>
      <ADMISSION_TYPE>EMERGENCY</ADMISSION_TYPE>
      <RELIGION>UNOBTAINABLE</RELIGION>
      <ADMISSION_SOURCE>PHYS REFERRAL/NORMAL DELI</ADMISSION_SOURCE>
      <OVERALL_PAYOR_GROUP>PRIVATE</OVERALL_PAYOR_GROUP>
      <MARITAL_STATUS>SINGLE</MARITAL_STATUS>
      <DOD>2013-08-15 06:28:10</DOD>
      <AGE_AT_DEATH>50</AGE_AT_DEATH>
      <AGE_AT_DEATH_GRP>35-64</AGE_AT_DEATH_GRP>
    </PATIENT>
    <DRG>
      <CODE>541</CODE>
      <ITEMID>60775</ITEMID>
      <DESC>ECMO OR TRACH W MV 96+HRS OR PDX EXC FAC</DESC>
      <COST_WEIGHT>19.8</COST_WEIGHT>
      <COST_WEIGHT_GRP>5.0+</COST_WEIGHT_GRP>
      <DISPLAY>(541)ECMO OR TRACH W MV 96+HRS OR PDX EXC FAC</DISPLAY>
    </DRG>
    <ICD9>(094.9)NEUROSYPHILIS UNSPECIFIED</ICD9>
    <ICD9>(456.20)ESOPHAGEAL VARICES IN DISEASES CLASSIFIED ELSEWHER</ICD9>
    <ICD9>(599.0)URINARY TRACT INFECTION SITE NOT SPECIFIED</ICD9>
    <ICD9>(518.82)OTHER PULMONARY INSUFFICIENCY NOT ELSEWHERE CLASSI</ICD9>
    <ICD9>(296.20)MAJOR DEPRESSIVE AFFECTIVE DISORDER SINGLE EPISODE</ICD9>
    <ICD9>(112.5)DISSEMINATED CANDIDIASIS</ICD9>
    <ICD9>(272.4)OTHER AND UNSPECIFIED HYPERLIPIDEMIA</ICD9>
    <ICD9>(E879.8)OTHER SPECIFIED PROCEDURES AS THE CAUSE OF ABNORMA</ICD9>
    <ICD9>(V64.3)PROCEDURE NOT CARRIED OUT FOR OTHER REASONS</ICD9>
    <ICU>
      <COUNT>1</COUNT>
      <ICU>
        <ICUSTAY_ID>949195</ICUSTAY_ID>
        <FIRST_CAREUNIT>MICU</FIRST_CAREUNIT>
        <LAST_CAREUNIT>MICU</LAST_CAREUNIT>
        <INTIME>2013-08-06 10:28:10</INTIME>
        <OUTTIME>2013-08-15 06:28:10</OUTTIME>
        <LOS>12960</LOS>
        <LOS_GRP>10000-&lt;15000</LOS_GRP>
        <MEDEVENTS>
          <EVENT>
            <NAME>Propofol</NAME>
            <OCCURRENCES>83</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Nitroglycerine-k</NAME>
            <OCCURRENCES>2</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Nitroprusside</NAME>
            <OCCURRENCES>57</OCCURRENCES>
          </EVENT>
        </MEDEVENTS>
      </ICU>
    </ICU>
    <POEEVENTS>
      <EVENT>
        <NAME>-NF- Nifedipine XL</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lisinopril</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Norepinephrine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Prochlorperazine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Heparin Flush CVL  100 units per ml</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Amitriptyline HCl</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Simethicone</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Chloride</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Chl 20 mEq  per  1000 mL D5 half NS</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Doxycycline Hyclate</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Iso-Osmotic Dextrose</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Albuterol</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Diltiazem Extended-Release</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Phenylephrine HCl</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Haloperidol</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Epoetin Alfa</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Propofol</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Phenylephrine HCl</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Propofol</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Magnesium Sulfate</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bisacodyl</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Dextrose 5 percent</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Vial</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Diphenhydramine HCl</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Heparin</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Famotidine</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Desmopressin Acetate</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Atazanavir</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Magnesium Oxide</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Oxycodone-Acetaminophen</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Dextrose 5 percent</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Albuterol Sulfate-Ipratropium</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Scopolamine Patch</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Warfarin</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Metronidazole</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>HYDROmorphone Dilaudid</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Nitrofurantoin Macrodantin</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Neostigmine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Mycophenolate Mofetil Suspension</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Loperamide</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Furosemide</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lisinopril</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Famotidine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Diphenhydramine HCl</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Phenylephrine HCl</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Cinacalcet HCl</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Albuterol 0.083 percent Neb Soln</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Famotidine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Pantoprazole</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Syringe</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Fluconazole</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Metoprolol</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Norepinephrine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Methylprednisolone Na Succ.</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Atropine Sulfate</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Rosiglitazone Maleate</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ceftriaxone</NAME>
        <OCCURRENCES>9</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Calcium Gluconate</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Vial</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
    </POEEVENTS>
    <LABEVENTS>
      <EVENT>
        <NAME>Alanine aminotransferase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Magnesium Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>10</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Macrophages per 100 leukocytes in Pleural fluid by Manual count</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Prothrombin time PT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Microcytes Presence in Blood</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bilirubin Presence in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Magnesium Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>9</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Platelets  per volume in Blood</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Activated partial thrombplastin time aPTT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Specific gravity of Urine by Test strip</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Methadone Presence in Urine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>9</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Eosinophils  per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes Presence in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Moles per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Positive end expiratory pressure setting Ventilator</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lymphocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hemoglobin Presence in Urine by Test strip</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Activated partial thrombplastin time aPTT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Phosphate Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Myelocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocytes  per volume in Blood</NAME>
        <OCCURRENCES>9</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Oxygen.alveolar - arterial Partial pressure Respiratory system</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>INR in Blood by Coagulation assay</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Cholesterol.total per Cholesterol.in HDL Molar ratio in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes  per area in Urine sediment by Microscopy high power field</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Acanthocytes Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Collection duration of Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Activated partial thrombplastin time aPTT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Urea nitrogen Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>8</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lymphocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Benzodiazepines Presence in Urine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Tidal volume setting Ventilator</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hematocrit Volume Fraction of Blood</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Oxygen saturation in Blood</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Thyrotropin Units per volume in Blood</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Amylase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>pH of Urine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hemoglobin Mass per volume in Blood</NAME>
        <OCCURRENCES>10</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatinine Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>9</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Platelets Presence in Blood by Manual count</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sodium Moles per volume in Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Inhaled oxygen flow rate</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Poikilocytosis Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Globulin Mass per volume in Serum</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>CD22 cells per 100 cells in Body fluid</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Blood</NAME>
        <OCCURRENCES>53</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatine kinase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hematocrit Volume Fraction of Blood</NAME>
        <OCCURRENCES>18</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Fibrinogen Mass per volume in Platelet poor plasma by Coagulation assay</NAME>
        <OCCURRENCES>9</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes  per area in Urine sediment by Microscopy high power field</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hypochromia Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Protein Fractions interpretation in Urine by Electrophoresis</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Prothrombin time PT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lactate Moles per volume in Blood</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Phosphate Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>9</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>9</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anisocytosis Presence in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Color of Urine</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sodium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>11</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Opiates Presence in Urine</NAME>
        <OCCURRENCES>9</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Urine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anion gap in Blood</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Albumin Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Monocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular hemoglobin Entitic mass</NAME>
        <OCCURRENCES>10</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte distribution width Ratio</NAME>
        <OCCURRENCES>9</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatinine Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>22</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Specific gravity of Urine by Test strip</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glomerular filtration rate per 1.73 sq M.predicted by Creatinine-based formula MDRD</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hepatitis C virus Ab Presence in Serum</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>TBX5 gene mutations found Identifier in Blood or Tissue by Molecular genetics method Nominal</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Amphetamines Presence in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glomerular filtration rate per 1.73 sq M.predicted by Creatinine-based formula MDRD</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular hemoglobin Entitic mass</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Calcium.ionized Moles per volume in Blood</NAME>
        <OCCURRENCES>9</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Oxygen saturation in Blood</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Neutrophils.segmented per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
    </LABEVENTS>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>RN2</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>He was transfused for a hematocrit of 22. The posterior tibial artery occludes at the level of the midcalf. rt leg pale and warm lt leg flushed and warm with blood blister intact and various cuts in stages of healing. ? free h2o secondary to increased Na and osmo. A/p- ? team to talk w/ family, may approach CMO status as prognosis con't poor. Endocrine: cont on insulin gtt presently at 2u hr. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CCU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>Potassium and calcium repleted. Right profunda femoris artery is patent. Sats &gt;92%. talked to wife on phone. BS's very loose rhonchi. INTEG: PT TURNS/RP INDEPENDENTLY, NO AREAS SKIN BREAKDOWN NOTED. gu status: adeq uop despite ^ bun/creat. Pt then directly to T/Sicu. IMPRESSION: No acute pulmonary process. No prior MRIs are available at this institution. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RRT7</CAREGIVER>
      <TITLE>CCU Nursing transfer acceptance note</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>The distal popliteal artery is reconstituted via collaterals. The right lung is grossly clear. History of heroine abuse on methadone. Questionable allergy to ASA-GI bleed/red blotches? Will not treat w/ ASA per HO. Family meeting planned for tomorrow. PERRL.  Weakly palpale pulses in LE's. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>FICU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>BP 120-140's/50-60's, PAP30-40/15-20 unable to wedge,SICU fellow aware. This should be followed up as an out patient. IMPRESSION: 1. Improving congestive heart failure. 2. Continuing left lower lobe pneumonia. S/P TONSILLECTOMY 5 DAYS AGO @ LOCAL HOSPITAL FOR CANCER. Respiratory Care Note: Patient does not tolerate being off mask ventilation for very long before failing. heme/id: hct 26 no rx for now. wbc ^ . SKIN CARE, ? SPECIAL BED FOR SKIN ISSUES. SW will alert Sat on site SW of pts condition and encourage staff to pg on call SW as needed. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RN5</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Moderate, fixed anterior wall defect. He did have a nuclear scintigraphy scan confirming that he had some normal perfusion to his right brain, however, vastly diminished perfusion to his left brain. Please evaluate the left temporal lobe lesion. UNABLE TO PLACE PERIPHERAL ACCESS THEREFORE CENTRAL ACCESS LEFT IN PLACE. Therefore, the following history is per the ED team, the medical record, and the pt's wife. After the inner cannula was removed, the PICC was then advanced over the wire through the sheath under fluoroscopic guidance. no flatus. IMPRESSION: Slight decrease to left parietal cystic structure with catheter in place within the cyst. Retained barium is present throughout the colon from the prior video oropharyngogram. A+O. A large amount of perihepatic ascites is identified. SOCIAL: NO VISITORS OR PHONE INQUIRIES. There is a bleed on the head CT. As no suitable superficial veins were identified, ultrasound evaluation of the right upper extremity was performed which revealed the brachial vein to be patent and compressible. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RRT7</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>LUNGS DIMINISHED, I&amp;E WHEEZING BASES CLEAR SOMEWHAT WITH INHALERS. He has also been progressively lethargic and decreased energy per transfer note. T max 101.7. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>The gallbladder is not visualized. RR LOW TWENTIES, O2 SAT&gt;96%. COMPARISONS: None. There is no abnormal signal deep to the region of enhancement. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>RN3</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>? establish aggressiveness of treatment given number of compromised systems. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>MICU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>Nursing Progress Note</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>A negative FAST exam was recorded. VOIDING CLEAR YELLOW URINE. CONTINUES ON 100% HUMIDIFIED HALF MASK-POX- &gt;95%. AM K+ PENDING. abd soft and distended. no bm. ABD SOFT, BM X2 (SOFT, BROWN STOOL), TUBE FEEDS AT 40CC/HR AND NO RESIDUALS, FOLEY DRAINING CLEAR, YELLOW URINE. Calcification of the coronary arteries is present. REASON FOR THIS EXAMINATION: Please perform MRI with gadolinium and MRA to evaluate left temporal lesion. Repositioning helped a little, then resolved completely. Carcinoma of right tonsil as above  Decadron 0.75 mg Tablet Sig: Two (2) Tablet PO twice a day: take 2 tabs twice a day for the first 5 days, then decrease to 2 tabs once a day from there. FINAL REPORT CLINICAL INDICATION: Increased oxygen requirement in patient with coronary artery disease and CHF. NO STOOL. Gi/GU Foley to gravity Q.S. Hourly UOP. K+ down to 4. PAP 30-44/18-26, CVP 9-13, CO 6.11,CI 3.34 SVR 1100. Popliteal artery is occluded, however, there is reconstitution of the anterior tibial artery via lateral collaterals. </TEXT>
    </NOTEEVENT>
  </ADMISSION>
</DOCUMENT>
<DOCUMENT>
  <ADMISSION>
    <HADM_ID>47</HADM_ID>
    <PATIENT>
      <SUBJECT_ID>341565</SUBJECT_ID>
      <SEX>F</SEX>
      <AGE_AT_ADMISSION>87</AGE_AT_ADMISSION>
      <AGE_AT_ADMISSION_GRP>65+</AGE_AT_ADMISSION_GRP>
      <ADMISSION_DATE>2011-06-25 04:43:52</ADMISSION_DATE>
      <ADMISSION_DATE_YRMON>2011_06</ADMISSION_DATE_YRMON>
      <ADMISSION_DATE_MON_GRP>06</ADMISSION_DATE_MON_GRP>
      <ADMISSION_DATE_DAYMON_GRP>25</ADMISSION_DATE_DAYMON_GRP>
      <ADMISSION_DATE_DAYWEEK_GRP>6-Sat</ADMISSION_DATE_DAYWEEK_GRP>
      <ADMISSION_DATE_WEEK_GRP>25</ADMISSION_DATE_WEEK_GRP>
      <DISCHARGE_DATE>2011-06-28 18:43:52</DISCHARGE_DATE>
      <DOB>1924-04-03</DOB>
      <HOSPITAL_EXPIRE>N</HOSPITAL_EXPIRE>
      <ETHNICITY>WHITE</ETHNICITY>
      <ADMISSION_TYPE>EMERGENCY</ADMISSION_TYPE>
      <RELIGION>UNOBTAINABLE</RELIGION>
      <ADMISSION_SOURCE>EMERGENCY ROOM ADMIT</ADMISSION_SOURCE>
      <OVERALL_PAYOR_GROUP>MEDICARE</OVERALL_PAYOR_GROUP>
      <MARITAL_STATUS>WIDOWED</MARITAL_STATUS>
      <DOD>None</DOD>
      <AGE_AT_DEATH>(N/A)</AGE_AT_DEATH>
      <AGE_AT_DEATH_GRP>(N/A)</AGE_AT_DEATH_GRP>
    </PATIENT>
    <DRG>
      <CODE>089</CODE>
      <ITEMID>60144</ITEMID>
      <DESC>SIMPLE PNEUMONIA &amp;amp; PLEURISY AGE &amp;gt;17 WITH</DESC>
      <COST_WEIGHT>1.04</COST_WEIGHT>
      <COST_WEIGHT_GRP>1.0-&lt;1.3</COST_WEIGHT_GRP>
      <DISPLAY>(089)SIMPLE PNEUMONIA &amp;amp; PLEURISY AGE &amp;gt;17 WITH</DISPLAY>
    </DRG>
    <ICD9>(412)OLD MYOCARDIAL INFARCTION</ICD9>
    <ICD9>(V10.3)HX OF BREAST MALIGNANCY</ICD9>
    <ICD9>(276.4)MIXED ACID-BASE BAL DIS</ICD9>
    <ICD9>(V15.82)PERSONAL HISTORY OF TOBACCO USE</ICD9>
    <ICD9>(332.0)PARALYSIS AGITANS</ICD9>
    <ICD9>(285.1)AC POSTHEMORRHAG ANEMIA</ICD9>
    <ICD9>(441.7)THORACOABDOMINAL ANEURYSM WITHOUT RUPTURE</ICD9>
    <ICD9>(783.7)ADULT FAILURE TO THRIVE</ICD9>
    <ICD9>(518.82)OTHER PULMONARY INSUFFICIENCY NOT ELSEWHERE CLASSI</ICD9>
    <ICD9>(599.0)URINARY TRACT INFECTION SITE NOT SPECIFIED</ICD9>
    <ICU>
      <COUNT>1</COUNT>
      <ICU>
        <ICUSTAY_ID>849282</ICUSTAY_ID>
        <FIRST_CAREUNIT>CSRU</FIRST_CAREUNIT>
        <LAST_CAREUNIT>CSRU</LAST_CAREUNIT>
        <INTIME>2011-06-25 04:43:52</INTIME>
        <OUTTIME>2011-06-28 18:43:52</OUTTIME>
        <LOS>5760</LOS>
        <LOS_GRP>05000-&lt;07500</LOS_GRP>
        <MEDEVENTS>
          <EVENT>
            <NAME>Insulin</NAME>
            <OCCURRENCES>27</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Neosynephrine-k</NAME>
            <OCCURRENCES>9</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Propofol</NAME>
            <OCCURRENCES>10</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Insulin</NAME>
            <OCCURRENCES>27</OCCURRENCES>
          </EVENT>
        </MEDEVENTS>
      </ICU>
    </ICU>
    <POEEVENTS>
      <EVENT>
        <NAME>Senna</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ranitidine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Levofloxacin</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Citalopram Hydrobromide</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Heparin</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Phenazopyridine HCl</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Insulin</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Nystatin Oral Suspension</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>D5W</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hydralazine HCl</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sodium Chloride 0.9 percent  Flush</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Famotidine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Midazolam HCl</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Atorvastatin</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Cefazolin</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lisinopril</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Nitroprusside Sodium</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Famotidine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Pantoprazole</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
    </POEEVENTS>
    <LABEVENTS>
      <EVENT>
        <NAME>Amorphous sediment Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular hemoglobin concentration Mass per volume</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hematocrit Volume Fraction of Blood</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Cholesterol.in LDL Mass per volume in Serum or Plasma by calculation</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular volume Entitic volume</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Poikilocytosis Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatinine Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Aspartate aminotransferase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Activated partial thrombplastin time aPTT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Albumin Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Alanine aminotransferase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anisocytosis Presence in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anion gap in Blood</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lactate dehydrogenase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lactate Moles per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Positive end expiratory pressure setting Ventilator</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes Presence in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Eosinophils per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Phosphate Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Myelocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>None</NAME>
        <OCCURRENCES>11</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hematocrit Volume Fraction of Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Appearance of Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatine kinase.MB Mass per volume in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hypochromia Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Cobalamin Mass per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Yeast Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes  per volume in Blood</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes Presence in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Epithelial cells  per area in Urine sediment by Microscopy high power field</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Positive end expiratory pressure setting Ventilator</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lactate dehydrogenase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Microcytes Presence in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Monocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ovalocytes Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anion gap in Blood</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Fibrin D-dimer FEU Mass per volume in Platelet poor plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatinine Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Eosinophils per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hepatitis B virus surface Ag Presence in Serum</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte distribution width Ratio</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Chloride Moles per volume in Blood</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hemoglobin Mass per volume in Blood</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Triglyceride Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes  per area in Urine sediment by Microscopy high power field</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular hemoglobin Entitic mass</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Epithelial cells  per area in Urine sediment by Microscopy high power field</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glomerular filtration rate per 1.73 sq M.predicted by Creatinine-based formula MDRD</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Serum</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bacteria Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Carbon dioxide Partial pressure in Blood</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Aspartate aminotransferase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Iron Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Epithelial cells  per area in Urine sediment by Microscopy high power field</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatine kinase.MB Mass per volume in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Neutrophils.band form per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Thyrotropin Units per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Neutrophils.band form per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Troponin T.cardiac Mass per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocytes  per area in Urine sediment by Microscopy high power field</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatinine Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Platelets Presence in Blood by Manual count</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes Presence in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Positive end expiratory pressure setting Ventilator</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lactate dehydrogenase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Eosinophils per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Urobilinogen Mass per volume in Urine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Monocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Base excess in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lactate Moles per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anisocytosis Presence in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anisocytosis Presence in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Inhaled oxygen flow rate</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Oxygen.alveolar - arterial Partial pressure Respiratory system</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ovalocytes Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bilirubin Presence in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Haptoglobin Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hematocrit Volume Fraction of Blood</NAME>
        <OCCURRENCES>8</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Appearance of Urine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Haptoglobin Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Eosinophils per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Albumin Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Prothrombin time PT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sodium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>pH of Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Myelocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Vancomycin Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bacteria Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Platelets  per volume in Blood</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hemoglobin Presence in Urine by Test strip</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Urea nitrogen Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Oxygen per Inspired gas setting Volume Fraction Ventilator</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular hemoglobin Entitic mass</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatine kinase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Alkaline phosphatase Enzymatic activity per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Opiates Presence in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lymphocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>None</NAME>
        <OCCURRENCES>15</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Positive end expiratory pressure setting Ventilator</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anion gap in Blood</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Yeast Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glomerular filtration rate per 1.73 sq M.predicted by Creatinine-based formula MDRD</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>IgG Mass per volume in Serum</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Alkaline phosphatase Enzymatic activity per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Prothrombin time PT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes Presence in Urine</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Fibrinogen Mass per volume in Platelet poor plasma by Coagulation assay</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Carboxyhemoglobin per Hemoglobin.total in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Polychromasia Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Triacylglycerol lipase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anion gap in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocytes  per volume in Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
    </LABEVENTS>
    <NOTEEVENT>
      <CAREUNIT>MICU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>Profunda femoris is patent. Serial hematocrits were followed. Patchy atelectasis is also noted in the left retrocardiac region. INR 1.4. Liver team following ? Baseline 1ppd smoker. gi; refusing to take food and drink initially persuaded to take oj eventually at 830. Palate elevates symmetrically. CV: NSR-NO ECTOPY. ABG acceptable, RSBI 78 this am. Tolerated very well. Plan: Monitor hemodynamics. GI: pt able to swollow crushed pills with applesause without problems. Skin- intact on backside. RESP ACIDOSIS RESOLVED. rt leg pale and warm lt leg flushed and warm with blood blister intact and various cuts in stages of healing. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>POTASSIUM 3.2 AND REPLETED 40MEQ PO. Pupils fixed and dilated, NR. Lungs clear, diminished. Plan: Monitor hemodynamcis. GU: draining clear yellow urine. Then settled at 109. Picc-line. OOB to chair most of day, slow steady gait w/ assistance. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>MICU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Treated with Albuterol and Atrovent nebs with minimal effect. ABDOMINAL US: 1.Diffuse fatty infiltration of the liver. C02 51 (down from 66). MRA TECHNIQUE: 3D time-of-flight MRA of the head. A: FORGETFUL AND SLIGHTLY AGITATED BEARS WATCHING , LOPRESSOR WITH GOOD EFFECT. cvp 4-6 gu; u/o 40-60 mls /hr slightly blood stained at 1400 u/a and urine culture sent. RR 20-31. Platelets 143 (166). No evidence of hemorrhage or new lesions. No new hemorrhage is present. There are no aneurysms. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CCU</CAREUNIT>
      <CAREGIVER>RN6</CAREGIVER>
      <TITLE>Nursing progress notes 0700-1900</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>No nuchal rigidity Pulmonary: Lungs CTA bilaterally without R/R/W Cardiac: bradycardic, RR, nl. Assessment for hepatic mass is limited. 80 yo female admitted from cardiac cath lab s/p r renal artery stent. IMPRESSION: Status post catheter device placement within the left parietal cystic structure. Pan cultured yesterday. Plan: To extubate this am. FINAL REPORT PICC LINE PLACEMENT INDICATION: Left temporal astrocytoma, hemorrhage, bradycardia, need for IV therapy, failed bedside attempt. No evidence of pneumothorax. </TEXT>
    </NOTEEVENT>
  </ADMISSION>
</DOCUMENT>
<DOCUMENT>
  <ADMISSION>
    <HADM_ID>48</HADM_ID>
    <PATIENT>
      <SUBJECT_ID>185679</SUBJECT_ID>
      <SEX>M</SEX>
      <AGE_AT_ADMISSION>86</AGE_AT_ADMISSION>
      <AGE_AT_ADMISSION_GRP>65+</AGE_AT_ADMISSION_GRP>
      <ADMISSION_DATE>2013-02-09 04:38:19</ADMISSION_DATE>
      <ADMISSION_DATE_YRMON>2013_02</ADMISSION_DATE_YRMON>
      <ADMISSION_DATE_MON_GRP>02</ADMISSION_DATE_MON_GRP>
      <ADMISSION_DATE_DAYMON_GRP>09</ADMISSION_DATE_DAYMON_GRP>
      <ADMISSION_DATE_DAYWEEK_GRP>6-Sat</ADMISSION_DATE_DAYWEEK_GRP>
      <ADMISSION_DATE_WEEK_GRP>05</ADMISSION_DATE_WEEK_GRP>
      <DISCHARGE_DATE>2013-02-22 00:38:19</DISCHARGE_DATE>
      <DOB>1926-12-30</DOB>
      <HOSPITAL_EXPIRE>Y</HOSPITAL_EXPIRE>
      <ETHNICITY>WHITE</ETHNICITY>
      <ADMISSION_TYPE>EMERGENCY</ADMISSION_TYPE>
      <RELIGION>CATHOLIC</RELIGION>
      <ADMISSION_SOURCE>PHYS REFERRAL/NORMAL DELI</ADMISSION_SOURCE>
      <OVERALL_PAYOR_GROUP>MEDICARE</OVERALL_PAYOR_GROUP>
      <MARITAL_STATUS>NONE</MARITAL_STATUS>
      <DOD>2013-02-22 00:38:19</DOD>
      <AGE_AT_DEATH>86</AGE_AT_DEATH>
      <AGE_AT_DEATH_GRP>65+</AGE_AT_DEATH_GRP>
    </PATIENT>
    <DRG>
      <CODE>108</CODE>
      <ITEMID>60177</ITEMID>
      <DESC>OTHER CARDIOTHORACIC PROCEDURES</DESC>
      <COST_WEIGHT>5.36</COST_WEIGHT>
      <COST_WEIGHT_GRP>5.0+</COST_WEIGHT_GRP>
      <DISPLAY>(108)OTHER CARDIOTHORACIC PROCEDURES</DISPLAY>
    </DRG>
    <ICD9>(424.1)AORTIC VALVE DISORDER</ICD9>
    <ICD9>(V58.83)ENCOUNTER FOR THERAPEUTIC DRUG MONITORING</ICD9>
    <ICD9>(276.51)DEHYDRATION</ICD9>
    <ICD9>(410.11)ACUTE MYOCARDIAL INFARCTION OF OTHER ANTERIOR WALL</ICD9>
    <ICD9>(599.0)URINARY TRACT INFECTION SITE NOT SPECIFIED</ICD9>
    <ICD9>(456.20)ESOPHAGEAL VARICES IN DISEASES CLASSIFIED ELSEWHER</ICD9>
    <ICD9>(996.59)MALFUNC OTHER DEVICE/GRA</ICD9>
    <ICD9>(452)PORTAL VEIN THROMBOSIS</ICD9>
    <ICD9>(482.1)PNEUMONIA DUE TO PSEUDOMONAS</ICD9>
    <ICU>
      <COUNT>1</COUNT>
      <ICU>
        <ICUSTAY_ID>339625</ICUSTAY_ID>
        <FIRST_CAREUNIT>MICU</FIRST_CAREUNIT>
        <LAST_CAREUNIT>MICU</LAST_CAREUNIT>
        <INTIME>2013-02-09 04:38:19</INTIME>
        <OUTTIME>2013-02-22 00:38:19</OUTTIME>
        <LOS>18720</LOS>
        <LOS_GRP></LOS_GRP>
        <MEDEVENTS/>
      </ICU>
    </ICU>
    <POEEVENTS>
      <EVENT>
        <NAME>Pantoprazole</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Dextrose 50 percent</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Cosyntropin</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ceftriaxone</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Amlodipine</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>PredniSONE</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Multivitamin 12</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>K-Dur</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Aspirin EC</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>NS Glass Bottle</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Atorvastatin</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Warfarin</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Morphine Sulfate</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lorazepam</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Morphine Sulfate</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Docusate Sodium Liquid</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Insulin Human Regular</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Pneumococcal Vac Polyvalent</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Phenylephrine HCl</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Zolpidem Tartrate</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Olanzapine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Dextrose 50 percent</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sucralfate</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Metoprolol Tartrate</NAME>
        <OCCURRENCES>10</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Acetaminophen</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lactulose</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Heparin Sodium</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ranitidine</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Acetylcysteine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Nitroglycerin</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Insulin</NAME>
        <OCCURRENCES>16</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Iso-Osmotic Dextrose</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>NS</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
    </POEEVENTS>
    <LABEVENTS>
      <EVENT>
        <NAME>None</NAME>
        <OCCURRENCES>29</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Oxygen Partial pressure in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Blood</NAME>
        <OCCURRENCES>18</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes  per area in Urine sediment by Microscopy high power field</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Appearance of Urine</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Spherocytes Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Macrocytes Presence in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Magnesium Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>14</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Carbon dioxide Partial pressure in Blood</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Prothrombin time PT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>9</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Amylase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Platelets Presence in Blood by Manual count</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Activated partial thrombplastin time aPTT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>8</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular hemoglobin Entitic mass</NAME>
        <OCCURRENCES>13</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Amylase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte distribution width Ratio</NAME>
        <OCCURRENCES>15</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular volume Entitic volume</NAME>
        <OCCURRENCES>12</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>pH of Urine</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>13</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hemoglobin Presence in Urine by Test strip</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Albumin Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anion gap in Blood</NAME>
        <OCCURRENCES>8</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sodium Moles per volume in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Fibrin D-dimer FEU Mass per volume in Platelet poor plasma</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anisocytosis Presence in Blood</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bilirubin Presence in Urine</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Appearance of Urine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lactate Moles per volume in Blood</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Eosinophils per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte distribution width Ratio</NAME>
        <OCCURRENCES>15</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Color of Urine</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Neutrophils.band form per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Chloride Moles per volume in Blood</NAME>
        <OCCURRENCES>16</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes  per volume in Body fluid</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Globulin Mass per volume in Serum</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Magnesium Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>17</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lymphocytes Variant per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>pH of Urine</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ketones Mass per volume in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lactate Moles per volume in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Alanine aminotransferase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Moles per volume in Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Collection duration of Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Phosphate Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>13</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Blood</NAME>
        <OCCURRENCES>14</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes Presence in Urine</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Phosphate Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte distribution width Ratio</NAME>
        <OCCURRENCES>11</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ferritin Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Moles per volume in Serum or Plasma</NAME>
        <OCCURRENCES>14</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Potassium Moles per volume in Blood</NAME>
        <OCCURRENCES>56</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Prothrombin time PT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anion gap in Blood</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Serum</NAME>
        <OCCURRENCES>9</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Cholesterol.in LDL Mass per volume in Serum or Plasma by calculation</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Cholesterol.in HDL Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Appearance of Urine</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Positive end expiratory pressure setting Ventilator</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ferritin Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bacteria Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Amylase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Yeast Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Urobilinogen Mass per volume in Urine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Color of Urine</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Basophils per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocytes  per volume in Blood</NAME>
        <OCCURRENCES>15</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Oxygen Partial pressure in Blood</NAME>
        <OCCURRENCES>15</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Alkaline phosphatase Enzymatic activity per volume in Blood</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anion gap in Blood</NAME>
        <OCCURRENCES>13</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Troponin T.cardiac Mass per volume in Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Reticulocytes per 100 erythrocytes in Red Blood Cells by Automated count</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Eosinophils per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Blood</NAME>
        <OCCURRENCES>13</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lactate Moles per volume in Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Serum</NAME>
        <OCCURRENCES>13</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatinine Mass per volume in Urine</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Epithelial cells  per area in Urine sediment by Microscopy high power field</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocytes  per volume in Blood</NAME>
        <OCCURRENCES>14</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hemoglobin Presence in Urine by Test strip</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte distribution width Ratio</NAME>
        <OCCURRENCES>9</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Serum</NAME>
        <OCCURRENCES>13</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sodium Moles per volume in Blood</NAME>
        <OCCURRENCES>8</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Platelets  per volume in Blood</NAME>
        <OCCURRENCES>13</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatine kinase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Calcium.ionized Moles per volume in Blood</NAME>
        <OCCURRENCES>17</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Nitrite Presence in Urine by Test strip</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
    </LABEVENTS>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>CTIC/SICU NURSING NOTE</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT></TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>T-SICU</CAREUNIT>
      <CAREGIVER>RN7</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>The distal popliteal artery is reconstituted via collaterals. There is a thin rim of marginal enhancement present, which could represent residual or recurrent tumor. NEURO: SEDATED ON PROPOFOL FOR VENT SUPPORT AND LESSEN CHANCE OF REBLEED NON REPONSIVE TO PAINFUL STIMULI PUPILS 2 AND REACTIVE CARDIAC: EKG OK; HR PER MP 70'S NSR. Breath sounds slightly coarse in the bases no wheezes heard at time. MAE SPONT AND TO COMMAND. Local anesthesia was achieved with subcutaneous injection of 2 cc of 1% lidocaine. NEO OFF WITH SBP 120'S. ID: MRSA AND VRE IN WOUND- AFEBRILE. URINE OUTPUT 15-35ML/HR,MD AWARE. REASON FOR THIS EXAMINATION: picc line placement. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>2 Lasix 10 mg iv given post blood. No ectopy noted. Pulses present by doppler PT remain difficult to find but DP easily found. A large amount of perihepatic ascites is identified. Discussed with housestaff. resp; lung sounds diminished unable to do is encourage to deep breathe and cough. RR reg/unlabored. The common bile duct measures 3 mm and is not dilated. Pan cultured yesterday. Attempt wean IPS as tol. Pt on Bipap. C/O NAUSEA @ 1300 DRY HEAVES RECIEVED 10 MG IV REGLAN WITH GOOD EFFECT. An endotracheal tube has been slightly withdrawn in the interval but still terminates within the right main stem bronchus, but a more proximal level than before. Abdominal examination is unremarkable. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>RRT1</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>DISCHARGE_SUMMARY</CATEGORY>
      <TEXT>HRLY U/O&gt;35CC. GI: TOLERATING IMPACT WITH FIBER TUBE FEED ADVANCEMENT, NO RESIDUALS, OGT PLACEMENT CHECKED Q4H. Labetolol titrated with systolic currently 110-120, goal SBP&lt;140. At present time, last gas 7. HR 78-87. The patient was placed supine on the angiography table. -sensory: Briskly withdraws to tickle in all four extremities. CONTINUES ON 100% HUMIDIFIED HALF MASK-POX- &gt;95%. BS 153 treated with 5 units reg insulin sq. Non-ionic contrast was used due to patient debility. Stable left lower lobe atelectasis/infiltrates and layering left-sided effusion. Con't w/ family support. Received 230ml of contrast in cath lab. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>IMPRESSION: Successful placement of a 40 cm long single lumen PICC via the right brachial vein with the tip terminating in the SVC. We arec sxtn for scant to minimal secrettions fro ETT. ABD distended with Absent BS. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>RN5</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>REASON FOR THIS EXAMINATION: picc line placement. Family History: non-contributory  5 mg bid for 5 days and then to take 1. After the inner cannula was removed, the PICC was then advanced over the wire through the sheath under fluoroscopic guidance. Ph has improved from 7.21 to 7.28. bbs clear ^ lobes &amp; rt bases w crackles. Resp Care Note, Pt remains on current vent settings. Patchy atelectasis is also noted in the left retrocardiac region. Pulmonary was consulted, because of the CT and chest x-ray showing dependent consolidation with small bilateral pleural effusions and large ascus vein. 30ML THE LAST HOUR. Monitor per protocol. Stable overnight. O2 decreased to 1Lnc 7.28/56/61. IMPRESSION: Normal brain MRA. CV- SB-SR with occassional PACs. He was discharged home on POD3 without further event. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>RN5</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Distribution of bowel gas is unremarkable. No evidence of pneumonia. Carcinoma of right tonsil as above  The patient was treated with NS and fluid restriction, and sodium has improved to 125. There is a small fluid collection measuring 3.8 x 2.8 cm within the right rectus abdominis muscle. Pulmonary consult pending. Moderate left white matter edema has increased slightly compared to the preoperative exam. half hour, patient then extubated at 2145. Skin: L arm blister with increased weeping, increased edema. discussed w dr. Endocrine: requiring RISS coverage for hyperglycemia. Plan: ? Extubate soon and transition to oral intake. no flatus. Cont on fentanyl gtt at 150mcg/hr with minimal effect. Neuro: Rec'd patient agitated, unresponsive to orientation questions. LUNGS CLEAR IN UPPER LOBES AND DECREASED IN BASES. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT></TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT></TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RN1</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>IMPRESSION: A left temporal lobe subacute hematoma. There is cardiomegaly with slighlty prominent pulmonary vascularity consistent with improving congestive heart failure. Right profunda femoris artery is patent. Chest examination showed poor air movement bilaterally, but equal. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>Respiratory Care:</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>INTERPRETATION: Dobutamine was infused at 5 ug/kg/min. over 21 minutes. Continued left lower lobe collapse/consolidation. A limited renal ultrasound was performed at bedside. Bone piece removed from L frontal/parietal area and mod to large bloody drainage from wound. TECHNIQUE: Contiguous axial images were obtained from the lung apices through the lung bases and high resolution reconstructions were obtained. No intravenous or oral contrast was used. PULSES WEAK PALPABLE. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>MICU</CAREUNIT>
      <CAREGIVER>RRT9</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>Tone mildly increased on the right. IMPRESSION: Large fluid collection in the space of Retzius, with fluid-fluid level is indicative of a hematoma. The heart size is within normal limits. 20MG IV LASIX GIVEN X2 WITH GOOD DIURESIS. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RRT6</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>CV: NSR, SBP 90-110, NA 119, STARTED ON NS 60ML/HR AND 4HRLY LABS,AND AM LAB 120,CONTINUED NS SAME,MD AWARE, NEXT LAB DUE AT 0800. FOLEY DRAINING CLEAR YELLOW URINE. npn 0700-1500; events;received pt with aoox2-3. Right groin site intact. Tracer was injected 15 minutes prior to obtaining the rest images. Mild caliectasis of the left upper pole was seen. </TEXT>
    </NOTEEVENT>
  </ADMISSION>
</DOCUMENT>
<DOCUMENT>
  <ADMISSION>
    <HADM_ID>49</HADM_ID>
    <PATIENT>
      <SUBJECT_ID>61703</SUBJECT_ID>
      <SEX>F</SEX>
      <AGE_AT_ADMISSION>68</AGE_AT_ADMISSION>
      <AGE_AT_ADMISSION_GRP>65+</AGE_AT_ADMISSION_GRP>
      <ADMISSION_DATE>2012-08-14 04:16:46</ADMISSION_DATE>
      <ADMISSION_DATE_YRMON>2012_08</ADMISSION_DATE_YRMON>
      <ADMISSION_DATE_MON_GRP>08</ADMISSION_DATE_MON_GRP>
      <ADMISSION_DATE_DAYMON_GRP>14</ADMISSION_DATE_DAYMON_GRP>
      <ADMISSION_DATE_DAYWEEK_GRP>2-Tue</ADMISSION_DATE_DAYWEEK_GRP>
      <ADMISSION_DATE_WEEK_GRP>33</ADMISSION_DATE_WEEK_GRP>
      <DISCHARGE_DATE>2012-08-20 01:16:46</DISCHARGE_DATE>
      <DOB>1944-06-10</DOB>
      <HOSPITAL_EXPIRE>N</HOSPITAL_EXPIRE>
      <ETHNICITY>WHITE</ETHNICITY>
      <ADMISSION_TYPE>ELECTIVE</ADMISSION_TYPE>
      <RELIGION>UNOBTAINABLE</RELIGION>
      <ADMISSION_SOURCE>PHYS REFERRAL/NORMAL DELI</ADMISSION_SOURCE>
      <OVERALL_PAYOR_GROUP>MEDICARE-PRIVATE</OVERALL_PAYOR_GROUP>
      <MARITAL_STATUS>NONE</MARITAL_STATUS>
      <DOD>None</DOD>
      <AGE_AT_DEATH>(N/A)</AGE_AT_DEATH>
      <AGE_AT_DEATH_GRP>(N/A)</AGE_AT_DEATH_GRP>
    </PATIENT>
    <DRG>
      <CODE>542</CODE>
      <ITEMID>60778</ITEMID>
      <DESC>TRACH W MV 96+ HRS OR PDX EXC FACE, MOUT</DESC>
      <COST_WEIGHT>12.02</COST_WEIGHT>
      <COST_WEIGHT_GRP>5.0+</COST_WEIGHT_GRP>
      <DISPLAY>(542)TRACH W MV 96+ HRS OR PDX EXC FACE, MOUT</DISPLAY>
    </DRG>
    <ICD9>(294.10)DEMENTIA IN CONDITIONS CLASSIFIED ELSEWHERE WITHOU</ICD9>
    <ICD9>(276.51)DEHYDRATION</ICD9>
    <ICD9>(995.92)SYSTEMIC INFLAMMATORY RESPONSE SYNDROME DUE TO INF</ICD9>
    <ICD9>(599.0)URINARY TRACT INFECTION SITE NOT SPECIFIED</ICD9>
    <ICD9>(412)OLD MYOCARDIAL INFARCTION</ICD9>
    <ICD9>(518.83)CHRONIC RESPIRATORY FAILURE</ICD9>
    <ICD9>(V45.81)POSTSURGICAL AORTOCORONARY BYPASS STATUS</ICD9>
    <ICD9>(E849.7)ACCIDENTS OCCURRING IN RESIDENTIAL INSTITUTION</ICD9>
    <ICD9>(V15.82)PERSONAL HISTORY OF TOBACCO USE</ICD9>
    <ICD9>(584.5)LOWER NEPHRON NEPHROSIS</ICD9>
    <ICD9>(493.20)CHRONIC OBSTRUCTIVE ASTHMA, UNSPECIFIED</ICD9>
    <ICU>
      <COUNT>1</COUNT>
      <ICU>
        <ICUSTAY_ID>791681</ICUSTAY_ID>
        <FIRST_CAREUNIT>CCU</FIRST_CAREUNIT>
        <LAST_CAREUNIT>CCU</LAST_CAREUNIT>
        <INTIME>2012-08-14 04:16:46</INTIME>
        <OUTTIME>2012-08-20 01:16:46</OUTTIME>
        <LOS>8640</LOS>
        <LOS_GRP>07500-&lt;10000</LOS_GRP>
        <MEDEVENTS>
          <EVENT>
            <NAME>Labetolol</NAME>
            <OCCURRENCES>6</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Propofol</NAME>
            <OCCURRENCES>7</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Insulin</NAME>
            <OCCURRENCES>9</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Cisatracurium</NAME>
            <OCCURRENCES>12</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Vasopressin</NAME>
            <OCCURRENCES>8</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Neosynephrine-k</NAME>
            <OCCURRENCES>25</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Midazolam</NAME>
            <OCCURRENCES>41</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Levophed-k</NAME>
            <OCCURRENCES>13</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Propofol</NAME>
            <OCCURRENCES>12</OCCURRENCES>
          </EVENT>
          <EVENT>
            <NAME>Heparin</NAME>
            <OCCURRENCES>20</OCCURRENCES>
          </EVENT>
        </MEDEVENTS>
      </ICU>
    </ICU>
    <POEEVENTS/>
    <LABEVENTS>
      <EVENT>
        <NAME>Oxygen Partial pressure in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular volume Entitic volume</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lymphocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glomerular filtration rate per 1.73 sq M.predicted by Creatinine-based formula MDRD</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Monocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bacteria Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Color of Urine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Nitrite Presence in Urine by Test strip</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hemoglobin Mass per volume in Blood</NAME>
        <OCCURRENCES>8</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Eosinophils per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Basophilic stippling Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Yeast Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Cholesterol Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Protein Mass per volume in Urine by Test strip</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Neutrophils.segmented per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Transitional cells  per area in Urine sediment by Microscopy high power field</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Polychromasia Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Appearance of Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ketones Mass per volume in Urine</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Color of Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Troponin T.cardiac Mass per volume in Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lactate dehydrogenase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Yeast Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Lymphocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes  per area in Urine sediment by Microscopy high power field</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Serum</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bacteria Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Alkaline phosphatase Enzymatic activity per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Neutrophils.segmented per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Epithelial cells  per area in Urine sediment by Microscopy high power field</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Mitochondria Ab Presence in Serum</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Bicarbonate Moles per volume in Serum</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Protein Mass per volume in Urine by Test strip</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Chloride Moles per volume in Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Protein Mass per volume in Urine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>pH of Urine</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Thyrotropin Units per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Monocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatinine Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Yeast Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatine kinase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Iron Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Alanine aminotransferase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Basophils per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Hematocrit Volume Fraction of Blood</NAME>
        <OCCURRENCES>8</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Myelocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Chloride Moles per volume in Blood</NAME>
        <OCCURRENCES>8</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Burr cells Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte distribution width Ratio</NAME>
        <OCCURRENCES>6</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Alanine aminotransferase Enzymatic activity per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Creatine kinase.MB Mass per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular volume Entitic volume</NAME>
        <OCCURRENCES>7</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>INR in Blood by Coagulation assay</NAME>
        <OCCURRENCES>4</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Fibrinogen Mass per volume in Platelet poor plasma by Coagulation assay</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Activated partial thrombplastin time aPTT in Blood by Coagulation assay</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Glucose Mass per volume in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Sodium Moles per volume in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Eosinophils per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>2</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Anion gap in Blood</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Ferritin Mass per volume in Serum or Plasma</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Monocytes per 100 leukocytes in Blood</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Burr cells Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Basophilic stippling Presence in Blood by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Yeast Presence in Urine sediment by Light microscopy</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Urobilinogen Mass per volume in Urine</NAME>
        <OCCURRENCES>3</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Leukocytes Presence in Urine</NAME>
        <OCCURRENCES>1</OCCURRENCES>
      </EVENT>
      <EVENT>
        <NAME>Erythrocyte mean corpuscular volume Entitic volume</NAME>
        <OCCURRENCES>5</OCCURRENCES>
      </EVENT>
    </LABEVENTS>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>RRT5</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>B/S dim throughout Sx'd scant clear. Monitor SBP and maintain within parameters. C/O chest heaviness which resolved spontaneously. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>RN6</CAREGIVER>
      <TITLE>Nursing Note 7a-7p:</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>Albuterol multidose inhaler one to two puffs q 4 to 6 hours prn for wheezing,  Questionable corneals, impaired cough and no gag. He has history of PE and DVT post-op and will need to resume anticoagulation (lovenox) in 4-6 weeks. Updated per plan by RN and reinforced by NP. Local anesthesia was achieved with subcutaneous injection of 2 cc of 1% lidocaine. WILL ATTEMPT VENT WEAN AGAIN THIS AM. AM labs K+ 5.1. A large amount of perihepatic ascites is identified. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>MICU</CAREUNIT>
      <CAREGIVER>RN8</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>An endotracheal tube has been slightly withdrawn in the interval but still terminates within the right main stem bronchus, but a more proximal level than before. His last drink was five days prior to admission. + dopplerable DP bilat, + dopplerable PT bilat though difficult to find and weak, no change from earlier assessment. Pulmonary consulted and evaluated pt. There is no significant midline shift. No surrounding hemorrhage or mass effect. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>CSRU</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>Nursing/Other</CATEGORY>
      <TEXT>IMPRESSION: 1. Hyperdense material present within the surgical bed is consistent with acute blood products, at site of resected astrocytoma. H/H stable. Relief with neb rx. OGT to LCWS for sm. amt. BS's very loose rhonchi. post transfusion HCT 33. CV- BP as above, HR sinus, Hct slightly lower at 24.9 from 28.8. continues on po lopressor and captopril. Social- Family in and out all day. Monitor neuro checks q1hr, titrate labetolol/insulin gtts as needed. Palate elevates symmetrically. returned from ct scan pt initally aoox3 c/o of severe back pain then became increasingly somulent  A large amount of perihepatic ascites is identified. There is a thin rim of marginal enhancement present, which could represent residual or recurrent tumor. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>Check for followup status following diuresis. RCA 0%, distal LAD w/dissection. MAE WITH PURPOSEFUL MOVEMENT AND EQUAL STRENGTH. FINAL REPORT HISTORY: 64-year-old man with a left temporal astrocytoma. IMPRESSION: Decreased pulmonary edema. FOLLOW PAIN ASSESSMENT, ? PAIN SERVICE CONSULT. NEURO: SEDATED ON PROPOFOL FOR VENT SUPPORT AND LESSEN CHANCE OF REBLEED NON REPONSIVE TO PAINFUL STIMULI PUPILS 2 AND REACTIVE CARDIAC: EKG OK; HR PER MP 70'S NSR. </TEXT>
    </NOTEEVENT>
    <NOTEEVENT>
      <CAREUNIT>None</CAREUNIT>
      <CAREGIVER>None</CAREGIVER>
      <TITLE>None</TITLE>
      <CATEGORY>RADIOLOGY_REPORT</CATEGORY>
      <TEXT>GI/GU/ENDO: PT. He underwent a cardiac catheterization, which demonstrated three vessel disease. 0L and humidified O2 via face tent 40-100%. post transfusion HCT 33. </TEXT>
    </NOTEEVENT>
  </ADMISSION>
</DOCUMENT>

</DOCUMENTS>